Processing 00000000.tx.1: Genetic and host factors for dementia in Down's syndrome* NICOLE SCHUPF, PhD Laboratory of Epidemiology, New York State Institute for Basic Research in Developmental Disabilities, Staten Island Gertrude H. 

Phrase: "Genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "host factors for dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "in Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "* NICOLE SCHUPF,"

Phrase: "PhD Laboratory of Epidemiology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3244292:laboratory [Functional Concept]

Phrase: "New York State Institute for Basic Research"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0035172:Research Institute [Organization]
   748   C0021622:institute [Organization]
   748   C1272753:Institute [Idea or Concept]

Phrase: "in Developmental Disabilities,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0008073:Developmental Disabilities [Mental or Behavioral Dysfunction]
  1000   C1552527:Developmental Disabilities [Health Care Related Organization,Manufactured Object]
   861   C0231170:Disabilities [Finding]
   861   C0458003:Developmental [Qualitative Concept]
   861   C0678723:Developmental [Organism Function]
   789 E C0243107:development [Physiologic Function]
   789 E C1527148:Development [Functional Concept]
   777 E C0018576:Disabled [Patient or Disabled Group]
   777 E C1880351:Disabled [Qualitative Concept]

Phrase: "Staten Island Gertrude H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.2: Sergievsky Center, Columbia University College of Physicians and Surgeons, New York, USA Correspondence: Nicole Schupf, PhD, New York State Institute for Basic Research, 1050 Forest Hill Road, Staten Island, NY 10314. 

Phrase: "Sergievsky Center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205099:Center [Spatial Concept]

Phrase: "Columbia University College of Physicians"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0557806:College [Manufactured Object]

Phrase: "and"

Phrase: "Surgeons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582175:surgeons [Professional or Occupational Group]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "USA Correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "Nicole Schupf,"

Phrase: "PhD,"

Phrase: "New York State Institute for Basic Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0035172:Research Institute [Organization]
   748   C0021622:institute [Organization]
   748   C1272753:Institute [Idea or Concept]

Phrase: "1050 Forest Hill Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442650:Road [Manufactured Object]

Phrase: "Staten Island,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022130:Island [Geographic Area]

Phrase: "NY 10314."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027976:NY [Geographic Area]
   861   C1879958:NY [Intellectual Product]
Processing 00000000.tx.3: Tel: 001 718 494 5301; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "001 718 494 5301"

Phrase: ";"
Processing 00000000.tx.4: Fax: 001 718 494 5395; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "001 718 494 5395"

Phrase: ";"
Processing 00000000.tx.5: e-mail: ns24{at}columbia.edu Declaration of interest Grants IIRG-90-067 and RG3-96-077 from the Alzheimer's Association, Federal grants AG14673, HD35897, P50AG08702 and funds from New York State through its Office of Mental Retardation and Developmental Disabilities. 

Phrase: "e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "ns24{at}columbia.edu Declaration"

Phrase: "of interest Grants IIRG-90-067"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0018173:Grants [Quantitative Concept]
   804   C0439083:>90 [Quantitative Concept]
   804   C0439087:<90 [Quantitative Concept]
   804   C0543488:Interest [Mental Process]
   771 E C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "RG3-96-077 from the Alzheimer's Association,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "Federal grants AG14673,"

Phrase: "HD35897,"

Phrase: "P50AG08702"

Phrase: "and"

Phrase: "funds from New York State"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0027976:New York [Geographic Area]
   760   C0016820:Fund [Quantitative Concept]
   760   C0205314:New [Temporal Concept]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C3148680:State [Geographic Area]

Phrase: "through its Office"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442603:Office [Manufactured Object]

Phrase: "of Mental Retardation"
Meta Candidates (Total=10; Excluded=8; Pruned=0; Remaining=2)
  1000   C0025362:Mental Retardation [Mental or Behavioral Dysfunction]
   928 E C0079822:Mentally Retarded [Patient or Disabled Group]
   861   C0229992:mental [Mental Process]
   777 E C0229993:Psychic [Functional Concept]
   761 E C0011980:Diaphragm [Body Part, Organ, or Organ Component]
   761 E C0042241:DIAPHRAGM [Medical Device]
   761 E C1279038:Diaphragm [Body Part, Organ, or Organ Component]
   761 E C1705367:Diaphragm [Medical Device]
   750 E C0086045:mindfulness [Mental Process]
   750 E C3542996:Mindfulness [Mental Process]

Phrase: "and"

Phrase: "Developmental Disabilities."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0008073:Developmental Disabilities [Mental or Behavioral Dysfunction]
  1000   C1552527:Developmental Disabilities [Health Care Related Organization,Manufactured Object]
   861   C0231170:Disabilities [Finding]
   861   C0458003:Developmental [Qualitative Concept]
   861   C0678723:Developmental [Organism Function]
   789 E C0243107:development [Physiologic Function]
   789 E C1527148:Development [Functional Concept]
   777 E C0018576:Disabled [Patient or Disabled Group]
   777 E C1880351:Disabled [Qualitative Concept]
Processing 00000000.tx.6: * Presented in part as the Blake Marsh Lecture at the Annual Meeting of the Royal College of Psychiatrists, 6 July 2000, Edinburgh.  

Phrase: "*"

Phrase: "Presented in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449450:Presented [Idea or Concept]
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]
   756 E C0150312:Present [Quantitative Concept]

Phrase: "as the Blake Marsh Lecture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0376683:lecture [Intellectual Product]

Phrase: "at the Annual Meeting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0556656:Meeting [Health Care Activity]

Phrase: "of the Royal College"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0557806:College [Manufactured Object]

Phrase: "of Psychiatrists,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033872:Psychiatrists [Professional or Occupational Group]

Phrase: "6 July 2000,"

Phrase: "Edinburgh."
Processing 00000000.tx.7: ABSTRACT TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER AND OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES IN... 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   786   C0079399:Gender [Organism Attribute]
   786   C0804628:Gender [Clinical Attribute]
   786   C1522384:Gender [Organism Attribute]

Phrase: "AND"

Phrase: "OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021228:Individual Differences [Mental Process]
   779   C1705241:*Difference [Quantitative Concept]
   779   C1705242:Difference [Qualitative Concept]
   729 E C0443199:Differential [Qualitative Concept]

Phrase: "IN..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]
Processing 00000000.tx.8: DISCUSSION Clinical Implications and... 

Phrase: "DISCUSSION Clinical Implications"

Phrase: "and..."
Processing 00000000.tx.9: ACKNOWLEDGMENTS REFERENCES  Background The high risk for dementia in adults with Down's syndrome has been attributed to triplication and overexpression of the gene for amyloid precursor protein (APP). 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706907:Background [Conceptual Entity]

Phrase: "The high risk for dementia"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0332167:High Risk [Qualitative Concept]
   806   C3272283:High Risk [Finding]
   760   C0035647:Risk [Qualitative Concept]
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]

Phrase: "in adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001675:Adults [Age Group]
   966 E C1706450:Adult [Human]

Phrase: "with Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "has"

Phrase: "been"

Phrase: "attributed to triplication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0449234:Attribute [Idea or Concept]
   756   C1704772:Attribute [Conceptual Entity]
   756   C1882133:Attribute [Qualitative Concept]

Phrase: "and"

Phrase: "overexpression of the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "for amyloid precursor protein (APP)."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.10: But the wide variation in age at onset must be due to other risk factors. 

Phrase: "But"

Phrase: "the wide variation in age at onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:Variation [Qualitative Concept]

Phrase: "must"

Phrase: "be due to other risk factors."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0035648:risk factors [Quantitative Concept]
   790   C0678226:Due to [Functional Concept]
           due
   790   C1553898:risk factors [Idea or Concept]
   753   C0035647:Risk [Qualitative Concept]
   753   C2987476:Be [Conceptual Entity]
   753   C3146286:Due [Idea or Concept]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.11: Aims To identify factors which influence age at onset of dementia in Down's syndrome. 

Phrase: "Aims"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1947946:Aim [Idea or Concept]
  1000   C2948600:Aim [Pharmacologic Substance]
  1000   C3540471:AIM [Gene or Genome]
  1000   C3540472:AIM [Functional Concept]
  1000   C3540473:AIMS [Intellectual Product]

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "which"

Phrase: "influence"

Phrase: "age at onset of dementia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   835   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]
   760   C0332162:Onset [Qualitative Concept]

Phrase: "in Down's syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.12: Method Studies of factors which influence formation of beta-amyloid (A) were reviewed, including atypical karyotypes, susceptibility genotypes, gender and oestrogen deficiency, and individual differences in A peptide levels. 

Phrase: "Method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "Studies of factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0557651:Study [Manufactured Object]
   790   C0947630:studies [Laboratory Procedure]
   790   C2603343:Study [Research Activity]
   756   C1521761:Factor [Functional Concept]
   756   C2827422:Factor [Conceptual Entity]

Phrase: "which"

Phrase: "influence"

Phrase: "formation of beta-amyloid (A)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C2247791:beta-amyloid formation [Molecular Function]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "were"

Phrase: "reviewed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0282443:reviewed [Intellectual Product]
  1000   C1709940:Reviewed [Qualitative Concept]
   966 E C1552617:Review [Idea or Concept]

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "atypical karyotypes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022526:karyotypes [Laboratory Procedure]
   861   C0178725:karyotypes [Laboratory or Test Result]
   861   C1261273:Karyotypes [Organism Attribute]

Phrase: "susceptibility genotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "gender"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "and"

Phrase: "oestrogen deficiency,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0853662:estrogen deficiency [Disease or Syndrome]
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: "and"

Phrase: "individual differences in A peptide levels."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021228:Individual Differences [Mental Process]
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.13: Results The apolipoprotein E 4 allele, oestrogen deficiency and high levels of A1-42 peptide are associated with earlier onset of dementia, while atypical karyotypes and the apolipoprotein E 2 allele are associated with reduced mortality and reduced risk of dementia. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "The apolipoprotein E 4 allele,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "oestrogen deficiency"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0853662:estrogen deficiency [Disease or Syndrome]
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: "and"

Phrase: "high levels of A1-42 peptide"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "associated with earlier onset of dementia,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   773   C1833334:Early-onset [Finding]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0332162:Onset [Qualitative Concept]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
   719 E C0750490:Associate [Idea or Concept]
   719   C1279919:Early [Temporal Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "while"

Phrase: "atypical karyotypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022526:karyotypes [Laboratory Procedure]
   861   C0178725:karyotypes [Laboratory or Test Result]
   861   C1261273:Karyotypes [Organism Attribute]

Phrase: "and"

Phrase: "the apolipoprotein E 2 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0002085:Allele [Gene or Genome]
   756   C0052198:Apolipoprotein E-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "associated with reduced mortality"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0026565:Mortality [Quantitative Concept]
   770   C0026566:mortality [Quantitative Concept]
   770   C0392756:Reduced [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "reduced risk of dementia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.14: Conclusions Factors which influence A levels, rather than overexpression of APP, may account for the differences in age at onset of dementia in Down's syndrome.  

Phrase: "Conclusions Factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "which"

Phrase: "influence"

Phrase: "A levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "rather than"

Phrase: "overexpression of APP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "may"

Phrase: "account for the differences"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "in age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: "of dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "in Down's syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.15: INTRODUCTION TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER AND OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES IN... 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   786   C0079399:Gender [Organism Attribute]
   786   C0804628:Gender [Clinical Attribute]
   786   C1522384:Gender [Organism Attribute]

Phrase: "AND"

Phrase: "OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021228:Individual Differences [Mental Process]
   779   C1705241:*Difference [Quantitative Concept]
   779   C1705242:Difference [Qualitative Concept]
   729 E C0443199:Differential [Qualitative Concept]

Phrase: "IN..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]
Processing 00000000.tx.16: DISCUSSION Clinical Implications and... 

Phrase: "DISCUSSION Clinical Implications"

Phrase: "and..."
Processing 00000000.tx.17: ACKNOWLEDGMENTS REFERENCES  Alzheimer's disease is associated with characteristic neuropathology that includes the deposition of extracellular beta-amyloid (A) in neuritic plaques and intracellular accumulation of neurofibrillary tangles. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "associated with characteristic neuropathology"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   770   C1521970:Characteristic [Qualitative Concept]
   770   C1540677:neuropathology [Pathologic Function]
   770   C1555824:Neuropathology [Intellectual Product]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "that"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the deposition of extracellular beta-amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0011560:Amyloid deposition [Pathologic Function]
   783   C1705760:Amyloid Deposition [Finding]
   753   C0333562:Deposition [Functional Concept]

Phrase: "(A"

Phrase: ")"

Phrase: "in neuritic plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   789   C0027813:Neuritides [Disease or Syndrome]

Phrase: "and"

Phrase: "intracellular accumulation of neurofibrillary tangles."
Processing 00000000.tx.18: Adults with Down's syndrome have high levels of A deposition by age 40 years and early onset of dementia. 

Phrase: "Adults with Down's syndrome"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   802   C1863204:ADULT SYNDROME [Disease or Syndrome]
   802   C2720194:ADULT SYNDROME [Gene or Genome]
   770   C0001675:Adults [Age Group]
   737 E C1706450:Adult [Human]

Phrase: "have"

Phrase: "high levels of A deposition"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "by age 40 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C1510829:Age-Years [Temporal Concept]
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "early onset of dementia."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1833334:Early-onset [Finding]
   770   C0332162:Onset [Qualitative Concept]
   770   C1279919:Early [Temporal Concept]
Processing 00000000.tx.19: However, the average age at onset of clinical dementia is 55 years, and varies widely. 

Phrase: "However,"

Phrase: "the average age at onset of clinical dementia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   789   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   744   C0001779:Age [Organism Attribute]
   744   C0332162:Onset [Qualitative Concept]

Phrase: "is"

Phrase: "55 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "varies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548673:Varies [Intellectual Product]

Phrase: "widely."
Processing 00000000.tx.20: The neuropathological manifestations of Alzheimer's disease in Down's syndrome have been attributed to triplication and over-expression of the gene for beta-amyloid precursor protein (APP), located on chromosome 21, but the factors influencing age at onset of dementia are unresolved. 

Phrase: "The neuropathological manifestations of Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   773   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   753   C0205319:manifestations [Functional Concept]

Phrase: "in Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "have"

Phrase: "been"

Phrase: "attributed to triplication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0449234:Attribute [Idea or Concept]
   756   C1704772:Attribute [Conceptual Entity]
   756   C1882133:Attribute [Qualitative Concept]

Phrase: "and"

Phrase: "over-expression of the gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205136:Over [Spatial Concept]

Phrase: "for beta-amyloid precursor protein"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   923   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1750295:beta protein [Genetic Function]
   902   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2825879:Amyloid, Beta [Laboratory Procedure]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   812   C2004068:Beta [Qualitative Concept]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "located on chromosome 21,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0008664:Chromosome 21 [Cell Component]
   770   C0008633:Chromosome [Cell Component]

Phrase: "but"

Phrase: "the factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "influencing"

Phrase: "age at onset of dementia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   835   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]
   760   C0332162:Onset [Qualitative Concept]

Phrase: "are"

Phrase: "unresolved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443342:Unresolved [Qualitative Concept]
Processing 00000000.tx.21: Factors which influence formation and deposition of A are reviewed, including atypical karyotypes, susceptibility genotypes, gender and oestrogen deficiency, and individual differences in A peptide levels. 

Phrase: "Factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "which"

Phrase: "influence"

Phrase: "formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "deposition of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0011560:Amyloid deposition [Pathologic Function]
   858   C1705760:Amyloid Deposition [Finding]
   790   C0333562:Deposition [Functional Concept]

Phrase: "are"

Phrase: "reviewed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0282443:reviewed [Intellectual Product]
  1000   C1709940:Reviewed [Qualitative Concept]
   966 E C1552617:Review [Idea or Concept]

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "atypical karyotypes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022526:karyotypes [Laboratory Procedure]
   861   C0178725:karyotypes [Laboratory or Test Result]
   861   C1261273:Karyotypes [Organism Attribute]

Phrase: "susceptibility genotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "gender"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "and"

Phrase: "oestrogen deficiency,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0853662:estrogen deficiency [Disease or Syndrome]
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: "and"

Phrase: "individual differences in A peptide levels."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021228:Individual Differences [Mental Process]
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.22: Factors which modify the rate and degree of A deposition, rather than over-expression of APP, may be important determinants of risk for dementia in Down's syndrome.  

Phrase: "Factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "which"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "degree of A deposition,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "rather than"

Phrase: "over-expression of APP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0205136:Over [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "important determinants of risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1521761:Determinant [Functional Concept]

Phrase: "for dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "in Down's syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.23: AMYLOID CASCADE HYPOTHESIS TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER AND OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES IN... 

Phrase: "AMYLOID CASCADE HYPOTHESIS TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   785   C0079399:Gender [Organism Attribute]
   785   C0804628:Gender [Clinical Attribute]
   785   C1522384:Gender [Organism Attribute]

Phrase: "AND"

Phrase: "OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021228:Individual Differences [Mental Process]
   779   C1705241:*Difference [Quantitative Concept]
   779   C1705242:Difference [Qualitative Concept]
   729 E C0443199:Differential [Qualitative Concept]

Phrase: "IN..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]
Processing 00000000.tx.24: DISCUSSION Clinical Implications and... 

Phrase: "DISCUSSION Clinical Implications"

Phrase: "and..."
Processing 00000000.tx.25: ACKNOWLEDGMENTS REFERENCES  Although there has been controversy about the relative importance of plaques versus tangles in the development of Alzheimer's disease, there is increasing evidence that altered metabolism of A peptides and amyloid deposition in neuritic plaques causes Alzheimer's disease by triggering a complex pathological cascade that produces dementia. 

Phrase: "ACKNOWLEDGMENTS REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514811:Reference [Idea or Concept]
   827   C1706462:Reference [Conceptual Entity]

Phrase: "Although"

Phrase: "there"

Phrase: "has"

Phrase: "been"

Phrase: "controversy about the relative importance of plaques"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0680243:controversy [Social Behavior]

Phrase: "versus"

Phrase: "tangles in the development of Alzheimer's disease,"

Phrase: "there"

Phrase: "is"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that altered metabolism of A peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1158921:Peptide Metabolism [Molecular Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "amyloid deposition in neuritic plaques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0011560:Amyloid deposition [Pathologic Function]
   806   C1705760:Amyloid Deposition [Finding]
   760   C0333562:Deposition [Functional Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Alzheimer's disease by triggering"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "a complex pathological cascade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707310:Cascade [Manufactured Object]

Phrase: "that"

Phrase: "produces"

Phrase: "dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.26: The A peptides A1-40 and A1-42, the two major species of A, are generated from APP by sequential proteolytic cleavage by - and - secretases. 

Phrase: "The A peptides A1-40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   812   C0439509:/40 [Temporal Concept]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "A1-42,"

Phrase: "the two major species of A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705920:Species [Conceptual Entity]

Phrase: "are"

Phrase: "generated from APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]
   760   C3146294:Generated [Activity]

Phrase: "by sequential proteolytic cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "by -"

Phrase: "and -"

Phrase: "secretases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.27: These enzymes are not the only ones involved in the breakdown of APP: -secretase cleaves the full-length APP, producing soluble sAPP and, subsequently, p3. 

Phrase: "These enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the only ones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205447:One [Quantitative Concept]

Phrase: "involved in the breakdown of APP"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   822   C1327161:amyloid precursor protein breakdown [Molecular Function]
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C1623036:protein breakdown [Molecular Function]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0443161:break down [Qualitative Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0699900:breakdown [Organism Function]
   744   C1265875:breakdown [Acquired Abnormality]
   744   C1314939:Involved [Functional Concept]
   744   C1709634:Precursor [Idea or Concept]

Phrase: ": -"

Phrase: "secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cleaves"

Phrase: "the full-length APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "producing"

Phrase: "soluble sAPP"

Phrase: "and"

Phrase: ","

Phrase: "subsequently,"

Phrase: "p3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412751:P3 [Gene or Genome]
  1000   C1427831:P3 [Gene or Genome]
  1000   C1539372:p3 [Gene or Genome]
Processing 00000000.tx.28: Because processing by -secretase precludes production of full-length A peptides, it is anti-amyloidogenic (Younkin, 1998). 

Phrase: "Because"

Phrase: "processing by -secretase"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1709694:Processing [Activity]
   756 E C1184743:Process [Body Part, Organ, or Organ Component]
   756 E C1522240:Process [Phenomenon or Process]

Phrase: "precludes"

Phrase: "production of full-length A peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "it"

Phrase: "is"

Phrase: "anti-amyloidogenic"

Phrase: "(Younkin,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.29: Several lines of evidence suggest that deposition of A-42 is an important initial step in the pathogenesis of Alzheimer's disease. 

Phrase: "Several lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that deposition of A-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0011560:Amyloid deposition [Pathologic Function]
   797   C1705760:Amyloid Deposition [Finding]
   760   C0333562:Deposition [Functional Concept]

Phrase: "is"

Phrase: "an important initial step in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1261552:Step [Conceptual Entity]
   812   C1704379:Step [Functional Concept]
   812   C1705117:Step [Quantitative Concept]
   812   C2825408:Step [Manufactured Object]

Phrase: "the pathogenesis of Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0543483:pathogenesis [Functional Concept]
   760   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.30: A1-42 aggregates more rapidly and is deposited earlier in Alzheimer's disease plaques than A1-40 (Iwatsubo et al, 1994). 

Phrase: "A1-42 aggregates more rapidly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0205418:aggregates [Qualitative Concept]
   804   C1637379:Rapidly [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "deposited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:deposited [Functional Concept]

Phrase: "earlier in Alzheimer's disease plaques"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   781   C0679245:early disease [Temporal Concept]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0333463:plaques [Acquired Abnormality]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]
   726   C1279919:Early [Temporal Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "than A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "(Iwatsubo et al,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.31: Mutations in the gene for APP and in presenilin (PS1/2) genes are associated with early-onset familial Alzheimer's disease and with a selective increase in A1-42 (Borchelt et al, 1996; Mann et al, 1996; Scheuner et al, 1996; Kosaka et al, 1997; Younkin, 1998). 

Phrase: "Mutations in the gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C0596611:gene mutations [Genetic Function]
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "for APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and in presenilin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   790   C1515981:And [Idea or Concept]

Phrase: "(PS1/2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1418986:PRESENILIN 2 [Gene or Genome]
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "associated with early-onset familial Alzheimer's disease"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   870   C0750901:Alzheimer's disease with early onset [Disease or Syndrome]
           Alzheimer Disease, Early Onset
   814   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   800   C0814120:early disease onset [Disease or Syndrome]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   778   C1833334:Early-onset [Finding]
   774   C0243083:associated disease [Pathologic Function]
   774   C0277558:Familial disease [Disease or Syndrome]
   774   C0277793:disease onset [Temporal Concept]
   774   C0679245:early disease [Temporal Concept]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0015576:familial [Family Group]
   748   C0241888:Familial [Functional Concept]
   748   C0332162:Onset [Qualitative Concept]
   748   C1279919:Early [Temporal Concept]
   738 E C0344339:disease family [Finding]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and with a selective increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0442805:Increase [Functional Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "in A1-42"

Phrase: "(Borchelt et al,"

Phrase: "1996"

Phrase: "; Mann et al,"

Phrase: "1996"

Phrase: "; Scheuner et al,"

Phrase: "1996"

Phrase: "; Kosaka et al,"

Phrase: "1997"

Phrase: "; Younkin,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.32: Brain levels of A1-42 increase early in the development of Alzheimer's disease and are strongly correlated with cognitive decline (Cummings & Cotman, 1995; Naslund et al, 2000), and plasma levels of A1-42 are higher in elderly people who subsequently develop Alzheimer's disease than in those who remain free of dementia (Mayeux et al, 1999). 

Phrase: "Brain levels of A1-42"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0441889:Levels [Qualitative Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "early in the development of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0679245:early disease [Temporal Concept]
   748   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "are"

Phrase: "strongly"

Phrase: "correlated with cognitive decline"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
   770   C1516691:Cognitive [Functional Concept]
   770   C1707520:Correlated [Qualitative Concept]

Phrase: "(Cummings & Cotman,"

Phrase: "1995"

Phrase: "; Naslund et al,"

Phrase: "2000"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "plasma levels of A1-42"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0032105:Plasma [Body Substance]
   760   C0441889:Levels [Qualitative Concept]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "higher in elderly people"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "who subsequently"

Phrase: "develop"

Phrase: "Alzheimer's disease than"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0002395:Alzheimer's Disease [Disease or Syndrome]
   882   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C0012634:Disease [Disease or Syndrome]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]

Phrase: "in those"

Phrase: "who"

Phrase: "remain"

Phrase: "free of dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332296:free [Functional Concept]
   790   C1880497:Free [Qualitative Concept]
   790   C1996904:Free [Qualitative Concept]

Phrase: "(Mayeux et al,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.33: Virtually all individuals with Down's syndrome have neuropathological changes consistent with a diagnosis of Alzheimer's disease by the time they reach 40 years of age, including deposition of A in diffuse and neuritic plaques (Wisniewski, H. et al, 1995; Mann, 1988), and most will develop dementia by the end of their seventh decade of life (Lai & Williams, 1989). 

Phrase: "Virtually"

Phrase: "all individuals with Down's syndrome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0027361:Individual [Population Group]
   726   C0237401:Individual [Human]

Phrase: "have"

Phrase: "neuropathological changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "consistent with a diagnosis of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "by the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "they"

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "40 years of age,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C1510829:Age-Years [Temporal Concept]
   770   C0439234:years [Temporal Concept]
   737 E C0439508:/year [Temporal Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "deposition of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0011560:Amyloid deposition [Pathologic Function]
   858   C1705760:Amyloid Deposition [Finding]
   790   C0333562:Deposition [Functional Concept]

Phrase: "in diffuse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205219:Diffuse [Qualitative Concept]

Phrase: "and"

Phrase: "neuritic plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   789   C0027813:Neuritides [Disease or Syndrome]

Phrase: "(Wisniewski,"

Phrase: "H. et al,"

Phrase: "1995"

Phrase: "; Mann,"

Phrase: "1988"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "will"

Phrase: "develop"

Phrase: "dementia by the end of their seventh decade of life"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "(Lai & Williams,"

Phrase: "1989"

Phrase: ")."
Processing 00000000.tx.34: Despite the nearly universal occurrence of Alzheimer's disease pathology by middle age, there is wide variation in age at onset of dementia. 

Phrase: "Despite the nearly universal occurrence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243132:occurrence [Functional Concept]
   827   C1554210:occurrence [Idea or Concept]
   827   C2745955:Occurrence [Temporal Concept]

Phrase: "of Alzheimer's disease pathology"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "by middle age,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0026062:Middle Age [Temporal Concept]
  1000   C0205847:Middle Age [Age Group]
   861   C0001779:Age [Organism Attribute]
   861   C0444598:Middle [Spatial Concept]
   861   C0549183:middle [Spatial Concept]
   861   C1552826:middle [Idea or Concept]
   805 E C0205098:Medial [Spatial Concept]

Phrase: "there"

Phrase: "is"

Phrase: "wide variation in age at onset of dementia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:Variation [Qualitative Concept]
Processing 00000000.tx.35: The prevalence of Alzheimer's disease at age 65 has ranged between 30% and 75% (Zigman et al, 1997). 

Phrase: "The prevalence of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033105:Prevalence [Quantitative Concept]
   760   C0220900:prevalence [Quantitative Concept]

Phrase: "at age 65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001779:Age [Organism Attribute]
   861   C0450385:65 [Intellectual Product]

Phrase: "has"

Phrase: "ranged between 30%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "and"

Phrase: "75%"

Phrase: "(Zigman et al,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.36: Most studies have shown that the average age at onset of dementia is between 50 and 55 years, with a range from 38 to 70 years (Lai & Williams, 1989; Prasher & Krishnan, 1993). 

Phrase: "Most studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the average age at onset of dementia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   800   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   748   C0001779:Age [Organism Attribute]
   748   C0332162:Onset [Qualitative Concept]

Phrase: "is between 50"

Phrase: "and"

Phrase: "55 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "with a range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "from 38"

Phrase: "to 70 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(Lai & Williams,"

Phrase: "1989"

Phrase: "; Prasher & Krishnan,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.37: Methodological problems may account for some of the variation in estimated prevalence of Alzheimer's disease in Down's syndrome. 

Phrase: "Methodological problems"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1546466:Problems [Idea or Concept]
   827 E C0033213:Problem [Finding]

Phrase: "may"

Phrase: "account for some of the variation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205419:Variation [Qualitative Concept]
   753   C1551359:account [Idea or Concept]
   753   C2741673:Account # [Clinical Attribute]
   753   C2981730:Account [Classification]

Phrase: "in estimated prevalence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033105:Prevalence [Quantitative Concept]
   861   C0220900:prevalence [Quantitative Concept]

Phrase: "of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "in Down's syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.38: Diagnosis of Alzheimer's disease in this population requires both documentation of clinically significant decline in cognitive and adaptive competence from previously attained levels of performance and documentation of the absence of any other condition that might cause declines in performance (Aylward et al, 1997). 

Phrase: "Diagnosis of Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011900:Diagnosis [Finding]
   770   C1704338:diagnosis [Qualitative Concept]
   770   C1704656:DIAGNOSIS [Research Activity]

Phrase: "in this population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "requires"

Phrase: "both documentation of clinically significant decline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0175636:documentation [Health Care Activity]
   753   C0920316:Documentation [Intellectual Product]

Phrase: "in cognitive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516691:Cognitive [Functional Concept]

Phrase: "and"

Phrase: "adaptive competence from previously attained levels of performance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0086035:Competence [Qualitative Concept]

Phrase: "and"

Phrase: "documentation of the absence of any"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0175636:documentation [Health Care Activity]
   753   C0920316:Documentation [Intellectual Product]

Phrase: "other condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   928 E C0009647:Conditioned [Mental Process]
   928 E C1701901:Conditional [Qualitative Concept]
   928 E C1963686:Conditional [Functional Concept]
   900 E C1519605:Conditionality [Conceptual Entity]

Phrase: "that"

Phrase: "might"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "declines in performance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0597198:Performance [Individual Behavior]
   790   C1882330:Performance [Activity]

Phrase: "(Aylward et al,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.39: Both these requirements are particularly difficult to address for adults with Down's syndrome, given their lifelong intellectual disability. 

Phrase: "Both"

Phrase: "these requirements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514873:Requirement [Functional Concept]

Phrase: "are"

Phrase: "particularly difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0332218:Difficult [Qualitative Concept]
   755 E C1299586:Difficulty [Finding]

Phrase: "address for adults"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0001675:Adults [Age Group]
   790   C0376649:Address [Intellectual Product]
   790   C1442065:Address [Spatial Concept]
   756 E C1706450:Adult [Human]

Phrase: "with Down's syndrome,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "their lifelong intellectual disability."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0025362:Intellectual Disability [Mental or Behavioral Dysfunction]
   827   C0231170:Disability [Finding]
   755 E C0018576:Disabled [Patient or Disabled Group]
   755 E C1880351:Disabled [Qualitative Concept]
Processing 00000000.tx.40: The wide range of premorbid levels of performance associated with differences in level of intellectual disability requires specific criteria for clinically significant decline indicative of dementia for each level of function, and these are just beginning to be developed. 

Phrase: "The wide range of premorbid levels of performance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1514721:Range [Quantitative Concept]
   744   C2348147:Range [Quantitative Concept]
   744   C3542016:Range [Intellectual Product]

Phrase: "associated with differences"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "in level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of intellectual disability"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0025362:Intellectual Disability [Mental or Behavioral Dysfunction]
   861   C0231170:Disability [Finding]
   789 E C0018576:Disabled [Patient or Disabled Group]
   789 E C1880351:Disabled [Qualitative Concept]

Phrase: "requires"

Phrase: "specific criteria for clinically significant decline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0243161:criteria [Intellectual Product]

Phrase: "indicative of dementia"

Phrase: "for each level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "these"

Phrase: "are"

Phrase: "just"

Phrase: "beginning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Beginning [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "developed."
Processing 00000000.tx.41: There is, as yet, no consensus on a set of cognitive assessment tasks or on diagnostic criteria for existing cognitive assessment batteries that can differentiate adults with Down's syndrome who do and do not have dementia in its early stages. 

Phrase: "There"

Phrase: "is"

Phrase: ","

Phrase: "as yet,"

Phrase: "no consensus on a set of cognitive assessment tasks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0376298:Consensus [Social Behavior]

Phrase: "or on diagnostic criteria"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0679228:diagnostic criteria [Intellectual Product]
   770   C0011900:Diagnostic [Finding]
   770   C0243161:criteria [Intellectual Product]
   770   C0348026:Diagnostic [Functional Concept]

Phrase: "for existing cognitive assessment batteries"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0337088:batteries [Manufactured Object]
   779 E C0542351:Battery [Injury or Poisoning]

Phrase: "that"

Phrase: "can"

Phrase: "differentiate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205615:differentiate [Qualitative Concept]

Phrase: "adults with Down's syndrome"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   802   C1863204:ADULT SYNDROME [Disease or Syndrome]
   802   C2720194:ADULT SYNDROME [Gene or Genome]
   770   C0001675:Adults [Age Group]
   737 E C1706450:Adult [Human]

Phrase: "who"

Phrase: "do"

Phrase: "and"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "dementia in its early stages."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.42: Presently, most diagnoses of Alzheimer's disease in adults with Down's syndrome are made clinically, at relatively late stages of the disease, without systematic cognitive or functional testing over time. 

Phrase: "Presently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750528:presently [Idea or Concept]

Phrase: "most diagnoses of Alzheimer's disease"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0338067:diagnoses disease [Disease or Syndrome]
   760   C0011900:Diagnoses [Finding]
   726 E C1704338:diagnosis [Qualitative Concept]
   726 E C1704656:DIAGNOSIS [Research Activity]

Phrase: "in adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001675:Adults [Age Group]
   966 E C1706450:Adult [Human]

Phrase: "with Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "are"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "clinically,"

Phrase: "at relatively late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205087:Late [Temporal Concept]

Phrase: "stages of the disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   819   C0699749:disease stage [Diagnostic Procedure]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205390:Stage [Temporal Concept]
   770   C1300072:Stage [Clinical Attribute]
   770   C1306673:Stage [Qualitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "without systematic cognitive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516691:Cognitive [Functional Concept]

Phrase: "or"

Phrase: "functional testing over time."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   777   C0429928:testing times [Temporal Concept]
   770   C0039593:Testing [Functional Concept]
   770   C0392366:testing [Intellectual Product]
Processing 00000000.tx.43: The neuropathological manifestations of Alzheimer's disease in Down's syndrome have been attributed to triplication and overexpression of the gene for APP located on chromosome 21 (Rumble et al, 1989) and the increased risk of dementia in Down's syndrome may be mediated by an increased substrate for cellular production of A peptides. 

Phrase: "The neuropathological manifestations of Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   773   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   753   C0205319:manifestations [Functional Concept]

Phrase: "in Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "have"

Phrase: "been"

Phrase: "attributed to triplication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0449234:Attribute [Idea or Concept]
   756   C1704772:Attribute [Conceptual Entity]
   756   C1882133:Attribute [Qualitative Concept]

Phrase: "and"

Phrase: "overexpression of the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "for APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "located on chromosome 21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0008664:Chromosome 21 [Cell Component]
   770   C0008633:Chromosome [Cell Component]

Phrase: "(Rumble et al,"

Phrase: "1989"

Phrase: ")"

Phrase: "and"

Phrase: "the increased risk of dementia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0035647:Risk [Qualitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   751   C0234984:DEMENTIA ACQUIRED [Mental or Behavioral Dysfunction]

Phrase: "in Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "may"

Phrase: "be"

Phrase: "mediated by an increased substrate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1710236:Substrate [Manufactured Object]

Phrase: "for cellular production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "of A peptides."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.44: Recent neuropathological studies have shown that diffuse plaques, the most prevalent Alzheimer-type lesion seen in individuals with Down's syndrome before age 50, are not associated with dementia. 

Phrase: "Recent neuropathological studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that diffuse plaques,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333463:plaques [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "the most prevalent Alzheimer-type lesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0221198:Lesion [Finding]
   804   C1546698:Lesion [Intellectual Product]

Phrase: "seen in individuals"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   756   C0027361:Individual [Population Group]
   756 E C0042789:see [Organism Function]
   756   C0237401:Individual [Human]
   756 E C1947903:See [Activity]

Phrase: "with Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "before age 50,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with dementia."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.45: Diffuse plaques contain non-fibrillar amyloid, appear at younger ages than do neuritic plaques, are not associated with neuronal degeneration, and do not appear to affect the structure and function of neurons. 

Phrase: "Diffuse plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333463:plaques [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "non-fibrillar amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appear at younger ages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001779:Age [Organism Attribute]
   770   C0700364:APPEAR [Qualitative Concept]
   737   C0332239:Young [Temporal Concept]

Phrase: "than"

Phrase: "do"

Phrase: "neuritic plaques,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   789   C0027813:Neuritides [Disease or Syndrome]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with neuronal degeneration,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]
   770   C0011164:Degeneration [Pathologic Function]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1880269:Degeneration [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "function of neurons."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0031843:function [Physiologic Function]
   790   C0542341:Function [Functional Concept]
   790   C0700205:FUNCTION [Classification]
   790   C1705273:Function [Intellectual Product]
   718 E C0205245:Functional [Functional Concept]
   718 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.46: In contrast, increases in the numbers of neuritic plaques, containing substantial amounts of fibrillised A peptides, are observed in adults with Down's syndrome predominantly after 50 years of age and are associated with neuronal degeneration and loss of function (Wisniewski, T. et al, 1995). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "increases in the numbers of neuritic plaques,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   804   C0449793:Number of plaques [Quantitative Concept]
   778   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   748   C0237753:*Number [Quantitative Concept]
   748   C0442805:Increase [Functional Concept]
   748   C0449788:Number [Quantitative Concept]
   714 E C0011389:Plaque [Disease or Syndrome]
   714 E C0332461:Plaque [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "substantial amounts of fibrillised A peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "are"

Phrase: "observed in adults"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0001675:Adults [Age Group]
   790   C1441672:Observed [Functional Concept]
   756 E C1706450:Adult [Human]

Phrase: "with Down's syndrome predominantly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   827   C0039082:Syndrome [Disease or Syndrome]
   771   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   771   C2626739:Lanugo [Eukaryote]

Phrase: "after 50 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "are"

Phrase: "associated with neuronal degeneration"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]
   770   C0011164:Degeneration [Pathologic Function]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1880269:Degeneration [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "loss of function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1517945:Loss [Quantitative Concept]

Phrase: "(Wisniewski,"

Phrase: "T. et al,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.47: Examination of the age-specific prevalence of dementia in Down's syndrome supports the hypothesis that the clinical manifestations of Alzheimer's disease in Down's syndrome are closely associated with the development of these fibrillised plaques (Lai & Williams, 1989; Visser et al, 1997; Holland et al, 1998; Lai et al, 1999) (see Fig. 1). 

Phrase: "Examination of the age-specific prevalence of dementia"

Phrase: "in Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "the clinical manifestations of Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   773   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   753   C0205319:manifestations [Functional Concept]

Phrase: "in Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "are"

Phrase: "closely"

Phrase: "associated with the development of these fibrillised plaques"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0243107:development [Physiologic Function]
   744   C0333463:plaques [Acquired Abnormality]
   744   C0678723:Development [Organism Function]
   744   C1527148:Development [Functional Concept]
   711 E C0011389:Plaque [Disease or Syndrome]
   711 E C0332461:Plaque [Finding]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Lai & Williams,"

Phrase: "1989"

Phrase: "; Visser et al,"

Phrase: "1997"

Phrase: "; Holland et al,"

Phrase: "1998"

Phrase: "; Lai et al,"

Phrase: "1999"

Phrase: ")"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.48: Although prevalence studies have employed varying sampling and diagnostic methods, there is remarkable agreement across studies that risk of Alzheimer's disease increases primarily after 50 years of age. 

Phrase: "Although"

Phrase: "prevalence studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033106:Prevalence Studies [Quantitative Concept]
   861   C0033105:Prevalence [Quantitative Concept]
   861   C0220900:prevalence [Quantitative Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "varying"

Phrase: "sampling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441621:Sampling [Diagnostic Procedure]
  1000   C0870078:Sampling [Idea or Concept]

Phrase: "and"

Phrase: "diagnostic methods,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   983   C0430022:Diagnostic Method [Diagnostic Procedure]
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "there"

Phrase: "is"

Phrase: "remarkable agreement across studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680240:Agreement [Social Behavior]

Phrase: "that"

Phrase: "risk of Alzheimer's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C1281905:disease risk [Finding]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0035647:Risk [Qualitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "primarily after 50 years of age."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   783   C1510829:Age-Years [Temporal Concept]
   753   C0001779:Age [Organism Attribute]
   753   C0439234:years [Temporal Concept]
   719 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.49: In addition, not all adults with Down's syndrome will develop dementia even if they reach ages when the presence of high densities of neuritic plaques can be presumed. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all adults with Down's syndrome"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   781   C1863204:ADULT SYNDROME [Disease or Syndrome]
   781   C2720194:ADULT SYNDROME [Gene or Genome]
   760   C0001675:Adults [Age Group]
   726 E C1706450:Adult [Human]

Phrase: "will"

Phrase: "develop"

Phrase: "dementia even"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "if"

Phrase: "they"

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "ages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "when"

Phrase: "the presence of high densities of neuritic plaques"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "be"

Phrase: "presumed."
Processing 00000000.tx.50: Thus, while triplication of the gene for APP may serve to increase diffuse plaques in adults with Down's syndrome, factors distinct from APP triplication must account for individual differences in susceptibility to the formation of fibrillised plaques and for the wide range in age at onset of dementia. 

Phrase: "Thus,"

Phrase: "while"

Phrase: "triplication of the gene"

Phrase: "for APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "may"

Phrase: "serve"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "diffuse plaques in adults"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0333463:plaques [Acquired Abnormality]
   737 E C0011389:Plaque [Disease or Syndrome]
   737 E C0332461:Plaque [Finding]

Phrase: "with Down's syndrome,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "distinct from APP triplication"

Phrase: "must"

Phrase: "account for individual differences"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0021228:Individual Differences [Mental Process]
   770   C0027361:Individual [Population Group]
   770   C0237401:Individual [Human]
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "in susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0012655:Susceptibility [Clinical Attribute]
  1000   C0220898:Susceptibility [Organism Attribute]
  1000   C1264642:Susceptibility [Functional Concept]
  1000   C1547045:*Susceptibility [Quantitative Concept]
   928 E C0231204:Susceptible [Functional Concept]
   928 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of fibrillised plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333463:plaques [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "and for the wide range"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0332464:Wide [Spatial Concept]
   760   C1514721:Range [Quantitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "in age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: "of dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.51: A central task of the epidemiology of dementia in Down's syndrome is to identify factors that may influence risk of Alzheimer's disease by accelerating formation of A. 

Phrase: "A central task of the epidemiology of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3540678:Task [Occupational Activity]

Phrase: "in Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "may"

Phrase: "influence"

Phrase: "risk of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1281905:disease risk [Finding]
   770   C0035647:Risk [Qualitative Concept]

Phrase: "by accelerating formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "of A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.52: Several avenues of investigation are suggested by existing findings and I will review the role of (a) atypical karyotypes; 

Phrase: "Several avenues of investigation"

Phrase: "are"

Phrase: "suggested by existing findings"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0243095:Finding [Finding]
   737   C1705535:Suggest [Idea or Concept]
   737 E C2825141:Finding [Finding]

Phrase: "and"

Phrase: "I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "will"

Phrase: "review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "the role of (a) atypical karyotypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0022526:karyotypes [Laboratory Procedure]
   804   C0178725:karyotypes [Laboratory or Test Result]
   804   C1261273:Karyotypes [Organism Attribute]

Phrase: ";"
Processing 00000000.tx.53: (b) genetic susceptibility factors; 

Phrase: "(b) genetic susceptibility factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   886   C0033453:b factor [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   886   C0046774:B-factor [Nucleic Acid, Nucleoside, or Nucleotide]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.54: (c) gender and oestrogen deficiency; 

Phrase: "(c) gender"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0079399:Gender [Organism Attribute]
   861   C0804628:Gender [Clinical Attribute]
   861   C1522384:Gender [Organism Attribute]

Phrase: "and"

Phrase: "oestrogen deficiency"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0853662:estrogen deficiency [Disease or Syndrome]
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.55: and (d) individual differences in A peptide levels. 

Phrase: "and ("

Phrase: "d)"

Phrase: "individual differences in A peptide levels."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021228:Individual Differences [Mental Process]
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.56: View larger version (14K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.57: 1 Age-specific prevalence of dementia in adults with Down's syndrome. 

Phrase: "1 Age-specific prevalence of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033105:Prevalence [Quantitative Concept]
   753   C0220900:prevalence [Quantitative Concept]

Phrase: "in adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001675:Adults [Age Group]
   966 E C1706450:Adult [Human]

Phrase: "with Down's syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.58: , data from Lai & Williams (1989); 

Phrase: ", data from Lai & Williams"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "(1989"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.59: - - -, data from Visser et al (1997); 

Phrase: "- - -"

Phrase: ","

Phrase: "data from Visser et al (1997"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.60: , data from Lai et al (1999); 

Phrase: ", data from Lai et al (1999"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.61: ..., data from Holland et al (1998).   

Phrase: "...,"

Phrase: "data from Holland et al (1998"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.62: ATYPICAL KARYOTYPES TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER AND OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES IN... 

Phrase: "ATYPICAL KARYOTYPES TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   786   C0079399:Gender [Organism Attribute]
   786   C0804628:Gender [Clinical Attribute]
   786   C1522384:Gender [Organism Attribute]

Phrase: "AND"

Phrase: "OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021228:Individual Differences [Mental Process]
   779   C1705241:*Difference [Quantitative Concept]
   779   C1705242:Difference [Qualitative Concept]
   729 E C0443199:Differential [Qualitative Concept]

Phrase: "IN..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]
Processing 00000000.tx.63: DISCUSSION Clinical Implications and... 

Phrase: "DISCUSSION Clinical Implications"

Phrase: "and..."
Processing 00000000.tx.64: ACKNOWLEDGMENTS REFERENCES  There is evidence from case studies of adults with Down's syndrome that atypical karyotypes, including translocations, partial trisomies and varying degrees of mosaicism, are associated with improved survival and decreased risk of Alzheimer's disease. 

Phrase: "ACKNOWLEDGMENTS REFERENCES  There"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1514811:Reference [Idea or Concept]
   793   C1706462:Reference [Conceptual Entity]

Phrase: "is"

Phrase: "evidence from case studies of adults"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "with Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "that atypical karyotypes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022526:karyotypes [Laboratory Procedure]
   861   C0178725:karyotypes [Laboratory or Test Result]
   861   C1261273:Karyotypes [Organism Attribute]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "translocations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040715:Translocations [Cell or Molecular Dysfunction]
   966 E C2987521:Translocation [Activity]

Phrase: "partial trisomies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1297882:Trisomies, Partial [Congenital Abnormality]
   861   C0041107:Trisomies [Disease or Syndrome]
   861   C0728938:Partial [Quantitative Concept]
   861   C1550516:partial [Idea or Concept]

Phrase: "and"

Phrase: "varying degrees of mosaicism,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0449286:degrees [Quantitative Concept]
   770   C0542560:degrees [Intellectual Product]
   737 E C0441889:Degree [Qualitative Concept]
   737 E C1561545:degree [Quantitative Concept]
   737 E C2348088:Degree [Quantitative Concept]

Phrase: "are"

Phrase: "associated with improved survival"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0038952:Survival [Activity]
   770   C0184511:Improved [Qualitative Concept]
   770   C0220921:survival [Functional Concept]
   770   C0332272:Improved [Qualitative Concept]
   770   C1561611:Improved [Intellectual Product]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "decreased risk of Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.65: Prasher et al (1998) presented an interesting case of a 78-year-old woman with partial trisomy 21 [46,XX,rec(21)dup q, inv(21)(p12q22.1)] and conducted a comprehensive analysis of the clinical and molecular genetic correlates of the partial trisomy. 

Phrase: "Prasher et al (1998"

Phrase: ")"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "an interesting case of a 78-year-old woman"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0868928:Case [Functional Concept]
   742   C1706255:CASE [Medical Device]
   742   C1706256:Case [Conceptual Entity]

Phrase: "with partial trisomy 21"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0013080:Trisomy 21 [Congenital Abnormality,Disease or Syndrome]
   901   C1297882:Partial Trisomy [Congenital Abnormality]
   901   C3537167:Trisomy 21 [Cell or Molecular Dysfunction]
   827   C0041107:Trisomy [Disease or Syndrome]
   827   C0728938:Partial [Quantitative Concept]
   827   C1550516:partial [Idea or Concept]

Phrase: "[46,"

Phrase: "XX,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450371:XX [Organism Attribute]

Phrase: "rec(21"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424025:REC [Gene or Genome]

Phrase: ")"

Phrase: "dup q,"

Phrase: "inv(21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021943:inv [Cell or Molecular Dysfunction]
   861   C1425144:INV [Gene or Genome]

Phrase: ")"

Phrase: "(p12q22.1"

Phrase: ")"

Phrase: "]"

Phrase: "and"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "a comprehensive analysis of the clinical"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "molecular genetic correlates of the partial trisomy."
Processing 00000000.tx.66: While her general appearance was suggestive, but not typical, of the Down's syndrome phenotype, she experienced several of the common age-related medical conditions characteristic of Down's syndrome, including hypothyroidism, cataracts, hypotonia and hearing impairment. 

Phrase: "While"

Phrase: "her general appearance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1148118:General appearance [Clinical Attribute]
  1000   C1148438:General Appearance [Finding]
   861   C0205246:General [Spatial Concept]
   861   C0233426:Appearance [Organism Attribute]
   861   C0700364:Appearance [Qualitative Concept]
   861   C1553889:General [Idea or Concept]

Phrase: "was"

Phrase: "suggestive,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332299:suggestive [Functional Concept]

Phrase: "but"

Phrase: "not typical,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538928:Typical [Qualitative Concept]

Phrase: "of the Down's syndrome phenotype,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]
   734   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]

Phrase: "she"

Phrase: "experienced"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0237607:experience [Mental Process]
   966   C0596545:Experience [Mental Process]

Phrase: "several of the common age-related medical conditions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439064:Several [Quantitative Concept]
   744   C0443302:Several [Quantitative Concept]

Phrase: "characteristic of Down's syndrome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521970:Characteristic [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "hypothyroidism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020676:Hypothyroidism [Disease or Syndrome]

Phrase: "cataracts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086543:CATARACTS [Anatomical Abnormality]
  1000   C0521707:Cataracts [Acquired Abnormality]

Phrase: "hypotonia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026827:Hypotonia [Sign or Symptom]
   928 E C0241938:Hypotonic [Pathologic Function]

Phrase: "and"

Phrase: "hearing impairment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018772:hearing impairment [Finding]
  1000   C1384666:hearing impairment [Finding]
   861   C0684336:Impairment [Pathologic Function]
Processing 00000000.tx.67: Analysis of gene sequences on chromosome 21 using fluorescent in situ hybridisation showed that the partial trisomy excluded the region containing the gene for APP, which was present in only two copies. 

Phrase: "Analysis of gene sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "on chromosome 21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008664:Chromosome 21 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fluorescent in situ hybridisation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0162789:Fluorescent in Situ Hybridization [Molecular Biology Research Technique]
   923   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   861   C0444498:In situ [Spatial Concept]
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the partial trisomy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1297882:Partial Trisomy [Congenital Abnormality]
   861   C0041107:Trisomy [Disease or Syndrome]
   861   C0728938:Partial [Quantitative Concept]
   861   C1550516:partial [Idea or Concept]

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "the region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the gene for APP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0751455:gene protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0017337:Gene [Gene or Genome]

Phrase: "which"

Phrase: "was"

Phrase: "present in only two copies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
Processing 00000000.tx.68: There was no evidence of decline in cognitive or adaptive competence for the 5 years preceding her death from pneumonia, and no evidence of Alzheimer's disease found on magnetic resonance imaging or neuropathological assessment. 

Phrase: "There"

Phrase: "was"

Phrase: "no evidence of decline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in cognitive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516691:Cognitive [Functional Concept]

Phrase: "or"

Phrase: "adaptive competence for the 5 years"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0086035:Competence [Qualitative Concept]

Phrase: "preceding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:Preceding [Temporal Concept]

Phrase: "her death from pneumonia,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C1851438:Death from pneumonia [Finding]
   770   C0011065:Death [Organism Function]
   770   C1306577:Death, NOS [Finding]

Phrase: "and"

Phrase: "no evidence of Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   900   C1518340:No Evidence of Disease [Finding]
   806   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "found on magnetic resonance imaging"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   862   C0024485:Magnetic Resonance Imaging [Diagnostic Procedure]
   862   C1552358:Magnetic Resonance Imaging [Professional or Occupational Group]
   806   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   806   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   806   C1551403:Magnetic resonance [Laboratory Procedure]
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0024488:Magnetic [Occupation or Discipline]
   760   C0079595:Imaging [Diagnostic Procedure]
   760   C0150312:Found [Quantitative Concept]
   760   C0231881:Resonance [Finding]
   760   C0459800:resonance [Natural Phenomenon or Process]
   760   C0563532:magnetic [Natural Phenomenon or Process]
   760   C0684213:Resonance [Qualitative Concept]
   726 E C0243095:Find [Finding]
   726 E C1704254:Image [Intellectual Product]
   726 E C1704922:Image [Entity]
   726 E C3542466:Image [Intellectual Product]

Phrase: "or"

Phrase: "neuropathological assessment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1261322:Assessment [Health Care Activity]
   861   C1516048:Assessment [Activity]
Processing 00000000.tx.69: Similarly there are two reports of women with Down's syndrome with 25% and 86% disomy for chromosome 21, respectively (Chicoine & McGuire, 1997; W. B. Zigman, personal communication, 2000). 

Phrase: "Similarly there"

Phrase: "are"

Phrase: "two reports of women"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0684224:Reports [Intellectual Product]
   770   C0700287:reports [Health Care Activity]
   737 E C3273238:Report [Intellectual Product]

Phrase: "with Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "with 25%"

Phrase: "and"

Phrase: "86% disomy for chromosome 21,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C1955211:Chromosome disomy [Clinical Attribute]

Phrase: "respectively"

Phrase: "(Chicoine & McGuire,"

Phrase: "1997"

Phrase: "; W. B. Zigman,"

Phrase: "personal communication,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086792:Personal Communication [Social Behavior]
   861   C0009452:Communication [Social Behavior]

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.70: Both women had a characteristic Down's syndrome phenotype and typical age-related medical conditions, including hypothyroidism and cataracts. 

Phrase: "Both women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "had"

Phrase: "a characteristic Down's syndrome phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031437:Phenotype [Organism Attribute]
   812   C1285572:Phenotype [Laboratory Procedure]

Phrase: "and"

Phrase: "typical age-related medical conditions,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   771   C0012634:condition [Disease or Syndrome]
   771   C0348080:Condition [Qualitative Concept]
   771   C1705253:Condition [Conceptual Entity]
   721 E C0009647:Conditioned [Mental Process]
   721 E C1701901:Conditional [Qualitative Concept]
   721 E C1963686:Conditional [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "hypothyroidism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020676:Hypothyroidism [Disease or Syndrome]

Phrase: "and"

Phrase: "cataracts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086543:CATARACTS [Anatomical Abnormality]
  1000   C0521707:Cataracts [Acquired Abnormality]
Processing 00000000.tx.71: The woman with 25% disomy for chromosome 21 died at age 83 following hospitalisation for a hip fracture and was free of dementia at her death, while the woman with 86% disomy is still living at age 74 and shows no evidence of dementia based on evaluations of cognitive and adaptive behaviour.  

Phrase: "The woman with 25% disomy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0043210:Woman [Population Group]

Phrase: "for chromosome 21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008664:Chromosome 21 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "died at age 83"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001779:Age [Organism Attribute]
   770   C0011065:Died [Organism Function]
   770   C1546956:Died [Finding]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "hospitalisation for a hip fracture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019993:Hospitalization [Health Care Activity]

Phrase: "and"

Phrase: "was"

Phrase: "free of dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332296:free [Functional Concept]
   790   C1880497:Free [Qualitative Concept]
   790   C1996904:Free [Qualitative Concept]

Phrase: "at her death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "while"

Phrase: "the woman with 86% disomy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0043210:Woman [Population Group]

Phrase: "is"

Phrase: "still"

Phrase: "living at age 74"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0001779:Age [Organism Attribute]
   770   C0376558:Living [Idea or Concept]
   737 E C1548795:Live [Qualitative Concept]
   737 E C1634625:% live [Qualitative Concept]
   737 E C2982691:Live [Activity]

Phrase: "and"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "no evidence of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "based on evaluations of cognitive"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0220825:Evaluations [Functional Concept]
   760   C1516691:Cognitive [Functional Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1261322:Evaluation [Health Care Activity]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "adaptive behaviour."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0085880:Adaptive behaviour [Individual Behavior]
   861   C0004927:Behavior [Individual Behavior]
   861   C2707008:Behavior [Clinical Attribute]
   789 E C2986890:Behavioral [Idea or Concept]
Processing 00000000.tx.72: GENETIC SUSCEPTIBILITY FACTORS TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER AND OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES IN... 

Phrase: "GENETIC SUSCEPTIBILITY FACTORS TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   785   C0079399:Gender [Organism Attribute]
   785   C0804628:Gender [Clinical Attribute]
   785   C1522384:Gender [Organism Attribute]

Phrase: "AND"

Phrase: "OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021228:Individual Differences [Mental Process]
   779   C1705241:*Difference [Quantitative Concept]
   779   C1705242:Difference [Qualitative Concept]
   729 E C0443199:Differential [Qualitative Concept]

Phrase: "IN..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]
Processing 00000000.tx.73: DISCUSSION Clinical Implications and... 

Phrase: "DISCUSSION Clinical Implications"

Phrase: "and..."
Processing 00000000.tx.74: ACKNOWLEDGMENTS REFERENCES  Four genes that increase risk of Alzheimer's disease have been identified. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Four genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "risk of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1281905:disease risk [Finding]
   770   C0035647:Risk [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.75: Mutations in three genes, APP, presenilin-1 (PS1) and presenilin-2 (PS2), are associated with early-onset familial forms of Alzheimer's disease that are transmitted as an autosomal dominant (Goate et al, 1991; Levy-Lehad et al, 1995; Sherrington et al, 1995). 

Phrase: "Mutations in three genes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C0596611:gene mutations [Genetic Function]
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "presenilin-1 (PS1)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "presenilin-2 (PS2),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "associated with early-onset familial forms of Alzheimer's disease"
Meta Candidates (Total=27; Excluded=4; Pruned=0; Remaining=23)
   912   C2931257:Early-onset familial form of Alzheimer disease [Disease or Syndrome]
   847   C0338445:Familial Alzheimer's disease of early onset [Disease or Syndrome]
   832   C0750901:Alzheimer's disease with early onset [Disease or Syndrome]
           Alzheimer Disease, Early Onset
   784   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   781   C0814120:early disease onset [Disease or Syndrome]
   764   C0002395:Alzheimer's Disease [Disease or Syndrome]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C1521724:Alzheimer's Disease [Pathologic Function]
   764   C1833334:Early-onset [Finding]
   762   C0243083:associated disease [Pathologic Function]
   762   C0277558:Familial disease [Disease or Syndrome]
   762   C0277793:disease onset [Temporal Concept]
   762   C0679245:early disease [Temporal Concept]
   748   C1832428:Familial form [Finding]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0015576:familial [Family Group]
   742   C0241888:Familial [Functional Concept]
   742   C0332162:Onset [Qualitative Concept]
   742   C0348078:forms [Qualitative Concept]
   742   C0376315:Forms [Manufactured Object]
   742   C1279919:Early [Temporal Concept]
   726 E C0344339:disease family [Finding]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1522492:Form [Functional Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "that"

Phrase: "are"

Phrase: "transmitted as an autosomal dominant"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0443147:Autosomal dominant [Intellectual Product]
   760   C0242781:Transmitted [Pathologic Function]
   760   C0332289:transmitted [Functional Concept]
   760   C0596142:autosomal [Cell Component]
   760   C1521797:Transmitted [Natural Phenomenon or Process]
   760   C1527180:Dominant [Functional Concept]

Phrase: "(Goate et al,"

Phrase: "1991"

Phrase: "; Levy-Lehad et al,"

Phrase: "1995"

Phrase: "; Sherrington et al,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.76: Homozygosity for a common variant of PS1, the 1-allele, has been associated with increased risk of Alzheimer's disease in some, but not at all, studies (Higuchi et al, 1996; Kehoe et al, 1996; Scott et al, 1996; Wragg et al, 1996). 

Phrase: "Homozygosity for a common variant of PS1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0019904:Homozygosity [Organism Attribute]

Phrase: "the 1-allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "associated with increased risk of Alzheimer's disease"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C0243083:associated disease [Pathologic Function]
   774   C1281905:disease risk [Finding]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0035647:Risk [Qualitative Concept]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   728   C0277564:Acquired disease [Disease or Syndrome]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in some,"

Phrase: "but"

Phrase: "not at all,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2984077:Not at all [Intellectual Product]
   790   C1518422:Not [Functional Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "(Higuchi et al,"

Phrase: "1996"

Phrase: "; Kehoe et al,"

Phrase: "1996"

Phrase: "; Scott et al,"

Phrase: "1996"

Phrase: "; Wragg et al,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.77: Only one study has examined the influence of PS1 alleles on risk of dementia in Down's syndrome. 

Phrase: "Only one study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the influence of PS1 alleles"

Phrase: "on risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "of dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "in Down's syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.78: In that study of adults with Down's syndrome, there were no significant differences in allele frequencies between individuals with dementia and age-matched individuals without dementia (Tyrrell et al, 1999). 

Phrase: "In that study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "of adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001675:Adults [Age Group]
   966 E C1706450:Adult [Human]

Phrase: "with Down's syndrome,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "there"

Phrase: "were"

Phrase: "no significant differences in allele frequencies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "between individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "with dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "age-matched individuals without dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0027361:Individual [Population Group]
   726   C0237401:Individual [Human]

Phrase: "(Tyrrell et al,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.79: Polymorphisms in the gene for apolipoprotein E (APOE) have been associated with risk for the more common late-onset Alzheimer's disease, that is, with onset after 65 years of age. 

Phrase: "Polymorphisms in the gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C0678951:gene polymorphisms [Genetic Function]
   770   C0032529:polymorphisms [Genetic Function]
   737 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "for apolipoprotein E (APOE)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "been"

Phrase: "associated with risk"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0035647:Risk [Qualitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for the more common late-onset Alzheimer's disease,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   827   C0002395:Alzheimer's Disease [Disease or Syndrome]
   827   C1521724:Alzheimer's Disease [Pathologic Function]
   799   C0012634:Disease [Disease or Syndrome]
   743 E C1836721:MALS [Finding]
   743 E C3538764:MALS [Gene or Genome]
   743 E C3540595:MAL [Gene or Genome]

Phrase: "that"

Phrase: "is"

Phrase: ","

Phrase: "with onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "after 65 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.80: There are three common variants of the gene for APOE, encoded for by three alleles, 2, 3 and 4. 

Phrase: "There"

Phrase: "are"

Phrase: "three common variants of the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:variants [Qualitative Concept]

Phrase: "for APOE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "encoded for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0679058:encoded [Mental Process]
   833   C2700640:Encoded [Activity]

Phrase: "by three alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4."
Processing 00000000.tx.81: In numerous cross-sectional and casecontrol studies, patients with Alzheimer's disease have been found to be significantly more likely than their peers to have one or more copies of the APOE 4 allele (Corder et al, 1993; Mayeux et al, 1993; Saunders et al, 1993). 

Phrase: "In numerous cross-sectional"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   865   C0552389:cross sections [Spatial Concept]
   827   C0205155:Sectional [Spatial Concept]
   827   C2828360:Cross [Conceptual Entity]
   755 E C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   755 E C1522472:Section [Substance]
   755 E C1552923:Section [Quantitative Concept]
   755 E C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "casecontrol studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "patients with Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "have"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "significantly more likely than their peers to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0332148:Likely [Qualitative Concept]
   748   C0679739:peers [Population Group]
   748   C0750492:Likely [Idea or Concept]

Phrase: "have"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "copies of the APOE 4 allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   814   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0002085:Allele [Gene or Genome]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1948062:Copies [Manufactured Object]

Phrase: "(Corder et al,"

Phrase: "1993"

Phrase: "; Mayeux et al,"

Phrase: "1993"

Phrase: "; Saunders et al,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.82: The APOE 4 protein may act by increasing the rate of the process which leads to Alzheimer's disease, predisposing to greater accumulation of A in those with and without Alzheimer's disease (Roses et al, 1994; Hyman et al, 1995; Polvikoski et al, 1995). 

Phrase: "The APOE 4 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "may"

Phrase: "act by increasing"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0079613:ACT [Therapeutic or Preventive Procedure]
   790   C0442808:Increasing [Functional Concept]
   756 E C0442805:Increase [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "the rate of the process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "which"

Phrase: "leads to Alzheimer's disease,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "predisposing to greater accumulation of A"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0231203:predisposing [Functional Concept]
   753   C0443228:greater [Quantitative Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1704243:Greater [Quantitative Concept]
   719 E C0549177:Great [Quantitative Concept]

Phrase: "in those with"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332287:With [Qualitative Concept]
  1000   C1705690:With [Intellectual Product]

Phrase: "and without Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1515981:And [Idea or Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(Roses et al,"

Phrase: "1994"

Phrase: "; Hyman et al,"

Phrase: "1995"

Phrase: "; Polvikoski et al,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.83: The presence of the least common allele, APOE 2, has been associated with a delay in disease onset or even protection by most investigators (Corder et al, 1994; Roses et al, 1994). 

Phrase: "The presence of the least common allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "APOE 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0052198:Apolipoprotein E-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "associated with a delay"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0205421:Delay [Temporal Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in disease onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0277793:disease onset [Temporal Concept]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "or"

Phrase: "even protection by most investigators"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1545588:Protection [Finding]

Phrase: "(Corder et al,"

Phrase: "1994"

Phrase: "; Roses et al,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.84: Apolipoprotein E in Down's syndrome The relation of APOE genotype to risk of Alzheimer's disease in Down's syndrome has been difficult to establish. 

Phrase: "Apolipoprotein E in Down's syndrome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "The relation of APOE genotype to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0080103:Relation [Family Group]
   748   C0869014:relation [Social Behavior]

Phrase: "risk of Alzheimer's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C1281905:disease risk [Finding]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0035647:Risk [Qualitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "in Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "has"

Phrase: "been"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "establish."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]
Processing 00000000.tx.85: All studies have consistently found that the presence of the APOE 2 allele increases longevity and reduces the risk of dementia but the role of the 4 allele has been controversial (Hardy et al, 1994; Royston et al, 1994; Martins et al, 1995; van Gool et al, 1995; Cosgrave et al, 1996; Lambert et al, 1996; Schupf et al, 1996; Prasher et al, 1997; Schupf et al, 1998; Sekijima et al, 1998; Tyrrell et al, 1998; Lai et al, 1999; Rubinszstein et al, 1999; Deb et al, 2000). 

Phrase: "All studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "consistently"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the presence of the APOE 2 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "longevity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023980:Longevity [Temporal Concept]

Phrase: "and"

Phrase: "reduces"

Phrase: "the risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "but"

Phrase: "the role of the 4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "controversial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0680243:controversies [Social Behavior]

Phrase: "(Hardy et al,"

Phrase: "1994"

Phrase: "; Royston et al,"

Phrase: "1994"

Phrase: "; Martins et al,"

Phrase: "1995"

Phrase: "; van Gool et al,"

Phrase: "1995"

Phrase: "; Cosgrave et al,"

Phrase: "1996"

Phrase: "; Lambert et al,"

Phrase: "1996"

Phrase: "; Schupf et al,"

Phrase: "1996"

Phrase: "; Prasher et al,"

Phrase: "1997"

Phrase: "; Schupf et al,"

Phrase: "1998"

Phrase: "; Sekijima et al,"

Phrase: "1998"

Phrase: "; Tyrrell et al,"

Phrase: "1998"

Phrase: "; Lai et al,"

Phrase: "1999"

Phrase: "; Rubinszstein et al,"

Phrase: "1999"

Phrase: "; Deb et al,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.86: Small sample sizes and, importantly, failure to consider differences in the age at onset of dementia among those with and without an 4 allele may account for some of the negative findings. 

Phrase: "Small sample sizes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0242618:Sizes, Sample [Quantitative Concept]
   896   C0748864:small size [Finding]
   827   C0456389:SIZES [Spatial Concept]

Phrase: "and"

Phrase: ","

Phrase: "importantly,"

Phrase: "failure to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "consider"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:consider [Idea or Concept]

Phrase: "differences in the age at onset of dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0699810:age differences [Age Group]
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "among those with"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332287:With [Qualitative Concept]
  1000   C1705690:With [Intellectual Product]

Phrase: "and without an 4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0002085:Allele [Gene or Genome]
   760   C1515981:And [Idea or Concept]

Phrase: "may"

Phrase: "account for some of the negative findings."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   762   C1513916:Negative Finding [Finding]
           Negative
   748   C0205160:Negative [Qualitative Concept]
   748   C1551359:account [Idea or Concept]
   748   C2607943:findings [Functional Concept]
   748   C2741673:Account # [Clinical Attribute]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]
   748   C2926606:Findings [Clinical Attribute]
   748   C2981730:Account [Classification]
   748   C3539655:Findings [Intellectual Product]
   714 E C0037088:Finding [Sign or Symptom]
   714 E C0243095:Finding [Finding]
   714 E C2825141:Finding [Finding]
Processing 00000000.tx.87: Since the effect of the 4 allele is not expressed until midlife, inclusion of sufficient numbers of adults over 50 years of age and analysis using survival methods that can adjust for age and years of follow-up are important methodological considerations. 

Phrase: "Since"

Phrase: "the effect of the 4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "expressed until midlife,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0026062:mid-life [Temporal Concept]

Phrase: "inclusion of sufficient numbers of adults"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1512693:Inclusion [Qualitative Concept]

Phrase: "over 50 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "survival methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "that"

Phrase: "can"

Phrase: "adjust for age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "years of follow-up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439234:years [Temporal Concept]
   737 E C0439508:/year [Temporal Concept]

Phrase: "are"

Phrase: "important methodological considerations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0518609:considerations [Finding]
Processing 00000000.tx.88: Our group used survival methods for analysis and found that the presence of the 4 allele was associated with earlier onset of dementia and greater decline in adaptive behaviour (Schupf et al, 1996). 

Phrase: "Our group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "survival methods for analysis"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   802   C2707190:Analysis method [Laboratory Procedure]
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0449851:Methods [Functional Concept]
   737 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the presence of the 4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "associated with earlier onset of dementia"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   773   C1833334:Early-onset [Finding]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0332162:Onset [Qualitative Concept]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
   719 E C0750490:Associate [Idea or Concept]
   719   C1279919:Early [Temporal Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "greater decline in adaptive behaviour"

Phrase: "(Schupf et al,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.89: Compared with those with the APOE 3/3 genotype, adults with Down's syndrome with an 4 allele were five times as likely to develop dementia by age 65, while no one with an 2 allele developed dementia (see Fig. 2). 

Phrase: "Compared with those with the APOE 3/3 genotype,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   782   C0052199:Apolipoprotein E-3 [Amino Acid, Peptide, or Protein]
   760   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0017431:Genotype [Organism Attribute]
   739   C1707455:Compared [Activity]

Phrase: "adults with Down's syndrome"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   802   C1863204:ADULT SYNDROME [Disease or Syndrome]
   802   C2720194:ADULT SYNDROME [Gene or Genome]
   770   C0001675:Adults [Age Group]
   737 E C1706450:Adult [Human]

Phrase: "with an 4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "were"

Phrase: "five times as likely to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "develop"

Phrase: "dementia by age 65,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "while"

Phrase: "no one with an 2 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0002085:Allele [Gene or Genome]
   753   C0205447:One [Quantitative Concept]

Phrase: "developed"

Phrase: "dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.90: Among affected individuals, mean age at onset of dementia was 53.3 years for those with the 4 allele and 58.0 years for those with the 3/3 genotype. 

Phrase: "Among affected individuals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "mean age at onset of dementia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   753   C0001779:Age [Organism Attribute]
   753   C0332162:Onset [Qualitative Concept]

Phrase: "was"

Phrase: "53.3 years for those with the 4 allele"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0439234:years [Temporal Concept]
   708 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "58.0 years for those with the 3/3 genotype."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0439234:years [Temporal Concept]
   706 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.91: Four other studies found an increased frequency of the 4 allele in adults with Down's syndrome and dementia compared with those with Down's syndrome without dementia (Martins et al, 1995; Sekijima et al, 1998; Rubinsztein et al, 1999; Deb et al, 2000). 

Phrase: "Four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "an increased frequency of the 4 allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0017270:Allele Frequency [Quantitative Concept]
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]

Phrase: "in adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001675:Adults [Age Group]
   966 E C1706450:Adult [Human]

Phrase: "with Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "and"

Phrase: "dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "compared with those with Down's syndrome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   753   C0039082:Syndrome [Disease or Syndrome]
   753   C1707455:Compared [Activity]

Phrase: "without dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "(Martins et al,"

Phrase: "1995"

Phrase: "; Sekijima et al,"

Phrase: "1998"

Phrase: "; Rubinsztein et al,"

Phrase: "1999"

Phrase: "; Deb et al,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.92: View larger version (13K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.93: 2 Cumulative incidence of dementia in adults with Down's syndrome by apolipoprotein E (APOE) genotype [UNK][UNK] APOE 3/4, 4/4 genotypes;  

Phrase: "2 Cumulative incidence of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "in adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001675:Adults [Age Group]
   966 E C1706450:Adult [Human]

Phrase: "with Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "by apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "[UNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1823916:UNK [Gene or Genome]

Phrase: "]"

Phrase: "[UNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1823916:UNK [Gene or Genome]

Phrase: "] APOE 3/4,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0052199:Apolipoprotein E-3 [Amino Acid, Peptide, or Protein]
   923   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   861   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "4/4 genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotypes [Organism Attribute]

Phrase: ";"
Processing 00000000.tx.94: APOE 3/3 genotype;  

Phrase: "APOE 3/3 genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017431:Genotype [Organism Attribute]
   717   C0052199:Apolipoprotein E-3 [Amino Acid, Peptide, or Protein]

Phrase: ";"
Processing 00000000.tx.95: APOE 2/2, 2/3, 2/4 genotypes. 

Phrase: "APOE 2/2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0052198:Apolipoprotein E-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "2/3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1519042:2-3 [Research Activity]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "2/4 genotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotypes [Organism Attribute]
Processing 00000000.tx.96: Based on Schupf et al (1996), by kind permission of Lippincott Williams & Wilkins.  

Phrase: "Based on Schupf et al (1996"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: ")"

Phrase: ","

Phrase: "by kind permission"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0521104:permission [Qualitative Concept]
   861   C1524004:Permission [Intellectual Product]

Phrase: "of Lippincott Williams & Wilkins."
Processing 00000000.tx.97: The results of other studies of APOE genotype in adults with Down's syndrome have been mixed. 

Phrase: "The results of other studies of APOE genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0683954:results studies [Finding]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "in adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001675:Adults [Age Group]
   966 E C1706450:Adult [Human]

Phrase: "with Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "have"

Phrase: "been"

Phrase: "mixed."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205430:Mixed [Functional Concept]
  1000   C3160715:Mixed [Finding]
   966 E C1421951:MIX [Gene or Genome]
   966 E C1720722:Mix [Qualitative Concept]
Processing 00000000.tx.98: Several studies that found that the APOE 2 allele decreased risk of dementia had sample sizes that were too small to demonstrate a significant effect of the 4 allele (Hardy et al, 1994; Royston et al, 1994; Wisniewski, T., et al, 1995). 

Phrase: "Several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the APOE 2 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0002085:Allele [Gene or Genome]
   756   C0052198:Apolipoprotein E-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]

Phrase: "had"

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "sizes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:SIZES [Spatial Concept]

Phrase: "that"

Phrase: "were"

Phrase: "too small to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0700321:Small [Quantitative Concept]

Phrase: "demonstrate"

Phrase: "a significant effect of the 4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "(Hardy et al,"

Phrase: "1994"

Phrase: "; Royston et al,"

Phrase: "1994"

Phrase: "; Wisniewski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "et al,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.99: Two casecontrol studies of adults with Down's syndrome compared allele frequencies in individuals with and without dementia and found no significant association between APOE genotype and Alzheimer's disease but did not adjust for age (van Gool et al, 1995; Prasher et al, 1997). 

Phrase: "Two casecontrol studies of adults"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "with Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "allele frequencies in individuals"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   833   C0017270:Frequencies, Allele [Quantitative Concept]
   770   C0439603:Frequencies [Temporal Concept]
   737 E C0376249:frequency [Quantitative Concept]
   737 E C0871396:Frequency [Quantitative Concept]
   737 E C1561548:Frequency [Qualitative Concept]
   737 E C1705502:Frequency [Quantitative Concept]

Phrase: "with"

Phrase: "and without dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]
   790   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no significant association between APOE genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "but"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "adjust for age (van Gool et al,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0001779:Age [Organism Attribute]
   748   C0557775:Van [Manufactured Object]

Phrase: "1995"

Phrase: "; Prasher et al,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.100: One large study examined 100 adults with Down's syndrome (40-70 years of age) and used survival analyses to examine age at onset of dementia by APOE genotype (Lai et al, 1999). 

Phrase: "One large study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "100 adults with Down's syndrome"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   781   C1863204:ADULT SYNDROME [Disease or Syndrome]
   781   C2720194:ADULT SYNDROME [Gene or Genome]
   760   C0001675:Adults [Age Group]
   726 E C1706450:Adult [Human]

Phrase: "(40-70 years of age)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C1510829:Age-Years [Temporal Concept]
   760   C0439234:years [Temporal Concept]
   726 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "used survival analyses to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0038953:Survival Analyses [Research Activity]
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "examine"

Phrase: "age at onset of dementia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   835   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]
   760   C0332162:Onset [Qualitative Concept]

Phrase: "by APOE genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Lai et al,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.101: The cumulative incidence of dementia by age 65 was 55% for those with the APOE 2/3 genotype, 88% for those with the APOE 3/3 genotype and 100% for those with any 4 allele. 

Phrase: "The cumulative incidence of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "by age 65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001779:Age [Organism Attribute]
   861   C0450385:65 [Intellectual Product]

Phrase: "was"

Phrase: "55% for those with the APOE 2/3 genotype,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   782   C0052198:Apolipoprotein E-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   777   C0052199:Apolipoprotein E-3 [Amino Acid, Peptide, or Protein]
   760   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0017431:Genotype [Organism Attribute]
   739   C0450382:55 [Intellectual Product]

Phrase: "88% for those with the APOE 3/3 genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   782   C0052199:Apolipoprotein E-3 [Amino Acid, Peptide, or Protein]
   760   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "100% for those with any 4 allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.102: The effect of the 4 allele was stronger at younger ages, consistent with findings from studies in the general population that the effect of the 4 allele is to accelerate onset of Alzheimer's disease (Corder et al, 1993; Saunders et al, 1993; Meyer et al, 1998). 

Phrase: "The effect of the 4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "stronger at younger ages,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0442821:Strong [Qualitative Concept]

Phrase: "consistent with findings"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   805   C0332529:Consistency finding [Qualitative Concept]
       E   Consistencies
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "from studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "in the general population"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683971:General Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "that"

Phrase: "the effect of the 4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "onset of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0277793:disease onset [Temporal Concept]
   770   C0332162:Onset [Qualitative Concept]

Phrase: "(Corder et al,"

Phrase: "1993"

Phrase: "; Saunders et al,"

Phrase: "1993"

Phrase: "; Meyer et al,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.103: Cumulative incidence to age 55 was 0.71 among those with an 4 allele and 0.40 among those with the APOE 3/3 genotype. 

Phrase: "Cumulative incidence to age 55"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "was"

Phrase: "0.71 among those with an 4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0002085:Allele [Gene or Genome]
   744   C0450389:71 [Intellectual Product]

Phrase: "and"

Phrase: "0.40 among those with the APOE 3/3 genotype."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   775   C0052199:Apolipoprotein E-3 [Amino Acid, Peptide, or Protein]
   756   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0017431:Genotype [Organism Attribute]
   738   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.104: The authors suggested that the 4 effect in their study may have been attenuated by the high rates of dementia at more advanced ages. 

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the 4 effect in their study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "have"

Phrase: "been"

Phrase: "attenuated by the high rates of dementia"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0205250:High [Qualitative Concept]
   748   C0332161:Attenuated [Qualitative Concept]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]
   748   C0599946:Attenuated [Activity]
   748   C1299351:High [Qualitative Concept]
   748   C2700149:HIGH [Intellectual Product]
   714   C0871208:Rate [Activity]
   714   C1521828:Rate [Quantitative Concept]

Phrase: "at more advanced ages."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0001792:Advanced age [Population Group]
   827   C0001779:Age [Organism Attribute]
Processing 00000000.tx.105: They concluded that the effect of the 4 allele may be dependent on the age of the study sample. 

Phrase: "They"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the effect of the 4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "dependent on the age of the study sample."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]
Processing 00000000.tx.106: These findings are consistent with reduced A deposition (Polvikoski et al, 1995) and less plaque formation (Benjamin et al, 1994; Lippa et al, 1994) in those with an 2 allele, and with acceleration of A pathology in those with an 4 allele (Hymen et al, 1995; Polvikoski et al, 1995). 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with reduced A deposition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(Polvikoski et al,"

Phrase: "1995"

Phrase: ")"

Phrase: "and"

Phrase: "less plaque formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "(Benjamin et al,"

Phrase: "1994"

Phrase: "; Lippa et al,"

Phrase: "1994"

Phrase: ")"

Phrase: "in those with an 2 allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "and with acceleration of A pathology"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0000894:Acceleration [Phenomenon or Process]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0030664:Pathology [Biomedical Occupation or Discipline]
   753   C0205469:pathology [Functional Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0677042:pathology [Pathologic Function]
   753   C1515981:And [Idea or Concept]

Phrase: "in those with an 4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "(Hymen et al,"

Phrase: "1995"

Phrase: "; Polvikoski et al,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.107: The size of the 4 effect, the relation of the presence of an 4 allele to early mortality and the interaction of APOE genotype with other risk factors for dementia in Down's syndrome such as gender and level of learning disability remain to be resolved. 

Phrase: "The size of the 4 effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0814843:effect size [Quantitative Concept]
   753   C0456389:size [Spatial Concept]

Phrase: "the relation of the presence of an 4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0080103:Relation [Family Group]
   742   C0869014:relation [Social Behavior]

Phrase: "to early mortality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026565:Mortality [Quantitative Concept]
   861   C0026566:mortality [Quantitative Concept]

Phrase: "and"

Phrase: "the interaction of APOE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "with other risk factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035648:risk factors [Quantitative Concept]
  1000   C1553898:risk factors [Idea or Concept]
   861   C0035647:Risk [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "for dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "in Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "such as gender"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "and"

Phrase: "level of learning disability"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "resolved."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514893:Resolved [Idea or Concept]
  1000   C2699488:Resolved [Conceptual Entity]
Processing 00000000.tx.108: This will require larger and older samples and analytic procedures which can provide better adjustment for age and other potential confounders.  

Phrase: "This"

Phrase: "will"

Phrase: "require"

Phrase: "larger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0443228:larger [Quantitative Concept]
  1000   C0549177:Larger [Quantitative Concept]
  1000   C1704243:Larger [Quantitative Concept]

Phrase: "and"

Phrase: "older samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "analytic procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "which"

Phrase: "can"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "better adjustment for age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0376209:Adjustment [Individual Behavior]
   770   C0456081:Adjustment [Functional Concept]
   770   C0683269:adjustment [Individual Behavior]

Phrase: "and"

Phrase: "other potential confounders."
Processing 00000000.tx.109: GENDER AND OESTROGEN DEFICIENCY TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER AND OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES IN... 

Phrase: "GENDER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "AND"

Phrase: "OESTROGEN DEFICIENCY TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   786   C0079399:Gender [Organism Attribute]
   786   C0804628:Gender [Clinical Attribute]
   786   C1522384:Gender [Organism Attribute]

Phrase: "AND"

Phrase: "OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021228:Individual Differences [Mental Process]
   779   C1705241:*Difference [Quantitative Concept]
   779   C1705242:Difference [Qualitative Concept]
   729 E C0443199:Differential [Qualitative Concept]

Phrase: "IN..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]
Processing 00000000.tx.110: DISCUSSION Clinical Implications and... 

Phrase: "DISCUSSION Clinical Implications"

Phrase: "and..."
Processing 00000000.tx.111: ACKNOWLEDGMENTS REFERENCES  Loss of gonadal hormones following menopause may be an important determinant of cognitive decline and risk for Alzheimer's disease in ageing women. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Loss of gonadal hormones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "menopause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025320:Menopause [Physiologic Function]
  1000   C0567312:Menopause [Finding]

Phrase: "may"

Phrase: "be"

Phrase: "an important determinant of cognitive decline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521761:Determinant [Functional Concept]

Phrase: "and"

Phrase: "risk for Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1281905:disease risk [Finding]
   770   C0035647:Risk [Qualitative Concept]

Phrase: "in ageing women."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]
Processing 00000000.tx.112: Before menopause, oestrogen promotes the growth and prolongs survival of cholinergic neurons in brain regions serving cognitive function (Toran-Allerand et al, 1992), increases cholinergic activity, has antioxidant properties and regulates the metabolism of the APP to protect against the formation of A (Jaffe et al, 1994; Goodman et al, 1996; Petanceska et al, 2000). 

Phrase: "Before menopause,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025320:Menopause [Physiologic Function]
  1000   C0567312:Menopause [Finding]

Phrase: "oestrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "prolongs"

Phrase: "survival of cholinergic neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1819944:neuron survival [Cell Function]
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]

Phrase: "in brain regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C1273723:brain regions [Body Location or Region]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "serving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519269:Serving [Quantitative Concept]

Phrase: "cognitive function"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0392335:cognitive function [Mental Process]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1516691:Cognitive [Functional Concept]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "(Toran-Allerand et al,"

Phrase: "1992"

Phrase: ")"

Phrase: ","

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "cholinergic activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "has"

Phrase: "antioxidant properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "and"

Phrase: "regulates"

Phrase: "the metabolism of the APP to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   822   C1327340:amyloid precursor protein metabolism [Molecular Function]
   767   C0597299:Protein Metabolism [Molecular Function]
   744   C0025519:Metabolism [Organism Function]
   744   C0025520:metabolism [Functional Concept]

Phrase: "protect against the formation of A"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1522492:Formation [Functional Concept]

Phrase: "(Jaffe et al,"

Phrase: "1994"

Phrase: "; Goodman et al,"

Phrase: "1996"

Phrase: "; Petanceska et al,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.113: In human studies, some, but not all, data show higher age-specific rates of Alzheimer's disease in women compared with men (Bachman et al, 1993) and approximately half the risk of Alzheimer's disease in women who have received oestrogen replacement therapy (Barrett-Conner & Kritz-Silverstein, 1993; Brenner et al, 1994; Henderson et al, 1994; Paganini-Hill & Henderson, 1994; Mortel & Meyer, 1995; Tang et al, 1996). 

Phrase: "In human studies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0178693:human studies [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "some,"

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all,"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "higher age-specific rates of Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0026538:disease rates [Quantitative Concept]
   714   C0871208:Rate [Activity]
   714   C1521828:Rate [Quantitative Concept]

Phrase: "in women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "compared with men (Bachman et al,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0025266:Men [Population Group]
   753   C1707455:Compared [Activity]
   719 E C0024554:MAN [Finding]
   719 E C0086418:Man [Human]

Phrase: "1993"

Phrase: ")"

Phrase: "and"

Phrase: "approximately half"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332232:Approximately [Qualitative Concept]
   861   C2825407:Half [Quantitative Concept]

Phrase: "the risk of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "in women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "who"

Phrase: "have"

Phrase: "received oestrogen replacement therapy"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   923   C0014935:Estrogen Replacement Therapy [Therapeutic or Preventive Procedure]
           Estrogen Replacement
   875   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]
   861   C0086258:Estrogen Replacement [Therapeutic or Preventive Procedure]
   861   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0035139:Replacement [Therapeutic or Preventive Procedure]
   812   C0039798:therapy [Functional Concept]
   812   C0087111:Therapy [Therapeutic or Preventive Procedure]
   812   C0559956:Replacement [Functional Concept]
   812   C1363945:Therapy [Finding]
   812   C1555302:Replacement [Idea or Concept]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(Barrett-Conner & Kritz-Silverstein,"

Phrase: "1993"

Phrase: "; Brenner et al,"

Phrase: "1994"

Phrase: "; Henderson et al,"

Phrase: "1994"

Phrase: "; Paganini-Hill & Henderson,"

Phrase: "1994"

Phrase: "; Mortel & Meyer,"

Phrase: "1995"

Phrase: "; Tang et al,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.114: Such findings support the hypothesis that oestrogen deficiency contributes to the aetiology of Alzheimer's disease. 

Phrase: "Such findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that oestrogen deficiency"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0853662:estrogen deficiency [Disease or Syndrome]
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: "contributes to the aetiology of Alzheimer's disease."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C1314792:disease etiology [Functional Concept]
           Aetiology
   748   C0012634:Disease [Disease or Syndrome]
   748   C0015127:aetiology [Functional Concept]
   748   C1524003:Etiology [Conceptual Entity]
   748   C1880177:Contribute [Activity]
Processing 00000000.tx.115: In contrast, randomised controlled clinical trials of oestrogen replacement therapy in women with moderate to severe Alzheimer's disease have failed to show cognitive improvement, suggesting that the major effect of oestrogen is to delay onset rather than reverse cognitive and functional decline (Henderson et al, 2000; Mulnard et al, 2000). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "randomised controlled clinical trials of oestrogen replacement therapy"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   793   C1515364:Clinical Trials, Therapy [Research Activity]
   770   C0008976:Clinical Trials [Research Activity]
           Trial
   770   C1096775:clinical trials [Intellectual Product]
   767   C0936233:Controlled Clinical Trial [Intellectual Product]
   744   C0205210:Clinical [Qualitative Concept]
   744   C2587213:Controlled [Functional Concept]
   711 E C0243148:control [Qualitative Concept]
   711 E C1550141:Control [Substance]
   711 E C1882979:Control [Conceptual Entity]
   711 E C3274648:Control [Qualitative Concept]

Phrase: "in women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "with moderate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205081:Moderate [Qualitative Concept]
  1000   C1881878:Moderate [Qualitative Concept]

Phrase: "to severe Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "have"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "cognitive improvement,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986411:Improvement [Conceptual Entity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the major effect of oestrogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0877035:Estrogen Effect [Finding]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "delay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205421:Delay [Temporal Concept]

Phrase: "onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "rather than"

Phrase: "reverse cognitive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516691:Cognitive [Functional Concept]

Phrase: "and"

Phrase: "functional decline"

Phrase: "(Henderson et al,"

Phrase: "2000"

Phrase: "; Mulnard et al,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.116: Gender differences and the effects of oestrogen in Down's syndrome have not been systematically investigated and more work is needed to clarify how hormonal risk factors may influence onset of dementia. 

Phrase: "Gender differences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0036866:gender differences [Organism Attribute]
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "and"

Phrase: "the effects of oestrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C0877035:Estrogen Effects [Finding]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "in Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "systematically"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "and"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "is"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "how hormonal risk factors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   906   C1512492:Hormonal Risk Factor [Qualitative Concept]
   861   C0035648:risk factors [Quantitative Concept]
   861   C1553898:risk factors [Idea or Concept]
   812   C0035647:Risk [Qualitative Concept]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "influence"

Phrase: "onset of dementia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332162:Onset [Qualitative Concept]
Processing 00000000.tx.117: Few studies have presented results separately for men and women. 

Phrase: "Few studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "presented results separately for men"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "and"

Phrase: "women."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]
Processing 00000000.tx.118: Studies that have compared women with men have found conflicting results, with different studies showing earlier onset (Raghaven et al, 1994; Lai et al, 1999), later onset (Farrer et al, 1997; Schupf et al, 1998) or no difference in age at onset (Visser et al, 1997; Lai & Williams, 1989) by gender. 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "have"

Phrase: "compared women with men"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043210:Women [Population Group]

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "conflicting results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "with different studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "earlier onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1833334:Early-onset [Finding]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "(Raghaven et al,"

Phrase: "1994"

Phrase: "; Lai et al,"

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "later onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332162:Onset [Qualitative Concept]

Phrase: "(Farrer et al,"

Phrase: "1997"

Phrase: "; Schupf et al,"

Phrase: "1998"

Phrase: ")"

Phrase: "or"

Phrase: "no difference in age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0699810:age difference [Age Group]
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "(Visser et al,"

Phrase: "1997"

Phrase: "; Lai & Williams,"

Phrase: "1989"

Phrase: ")"

Phrase: "by gender."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]
Processing 00000000.tx.119: Two studies employed survival methods to examine age at onset distributions by gender, adjusting for both age and level of learning disability, and found conflicting results. 

Phrase: "Two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "employed survival methods to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0025663:Methods [Intellectual Product]
   812   C0025664:methods [Intellectual Product]
   812   C0449851:Methods [Functional Concept]
   779 E C0871511:METHOD [Intellectual Product]

Phrase: "examine"

Phrase: "age at onset distributions by gender,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   783   C0001782:Distributions, Age [Quantitative Concept]
   753   C0037775:Distributions [Spatial Concept]
   719 E C0520511:distribution [Idea or Concept]
   719 E C1704711:Distribution [Functional Concept]

Phrase: "adjusting for both age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "level of learning disability,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "found conflicting results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]
Processing 00000000.tx.120: My colleagues and I found that men with Down's syndrome were three times as likely as women to develop Alzheimer's disease by age 65 (see Fig. 3a); 

Phrase: "My colleagues"

Phrase: "and"

Phrase: "I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that men with Down's syndrome"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0027662:MEN syndrome [Neoplastic Process]
   760   C0025266:Men [Population Group]
   726 E C0024554:MAN [Finding]
   726 E C0086418:Man [Human]

Phrase: "were"

Phrase: "three times as likely"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "as women to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]

Phrase: "develop"

Phrase: "Alzheimer's disease by age 65"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 3a"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.121: the effect of gender was observed in all age groups over 50 years (Schupf et al, 1998). 

Phrase: "the effect of gender"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "observed in all age groups"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0027362:Age Groups [Age Group]
   773 E C2348001:Age Group [Population Group]
   760   C0001779:Age [Organism Attribute]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1441672:Observed [Functional Concept]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "over 50 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(Schupf et al,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.122: Both men and women with Down's syndrome show elevations of follicle stimulating hormone (FSH) and luteinising hormone at puberty indicative of primary gonadal dysfunction, which appear to progress with age and be more frequent in men than in women (Hasen et al, 1980; Campbell et al, 1982; Hsiang et al, 1987; Hestnes et al, 1991). 

Phrase: "Both men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]

Phrase: "and"

Phrase: "women with Down's syndrome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043210:Women [Population Group]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "elevations of follicle stimulating hormone (FSH)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0702240:elevations [Spatial Concept]
   726 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "luteinising hormone at puberty"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   833   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0019932:Hormone [Hormone]

Phrase: "indicative of primary gonadal dysfunction,"

Phrase: "which"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "progress with age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001779:Age [Organism Attribute]
   790   C1272688:progress [Functional Concept]
   790   C1280477:Progress [Functional Concept]

Phrase: "and"

Phrase: "be"

Phrase: "more frequent in men"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332183:Frequent [Temporal Concept]

Phrase: "than"

Phrase: "in women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "(Hasen et al,"

Phrase: "1980"

Phrase: "; Campbell et al,"

Phrase: "1982"

Phrase: "; Hsiang et al,"

Phrase: "1987"

Phrase: "; Hestnes et al,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.123: Thus, older men may not benefit from the relative preservation of oestrogen proposed to account for lower risk of Alzheimer's disease in men in the general population. 

Phrase: "Thus,"

Phrase: "older men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0025266:Men [Population Group]
   827 E C0024554:MAN [Finding]
   827 E C0086418:Man [Human]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "benefit from the relative preservation of oestrogen"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   748   C0033085:Preservation [Laboratory Procedure]
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C0814225:Benefit [Quantitative Concept]
   748   C1514402:Preservation [Laboratory Procedure]
   748   C1547039:*Relative [Quantitative Concept]
   748   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "account for lower risk of Alzheimer's disease"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C1281905:disease risk [Finding]
   762   C3272281:Low Risk [Finding]
   762   C3538919:Low Risk [Quantitative Concept]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0035647:Risk [Qualitative Concept]
   748   C0441994:Lower [Spatial Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C1551359:account [Idea or Concept]
   748   C2003888:Lower [Activity]
   748   C2741673:Account # [Clinical Attribute]
   748   C2981730:Account [Classification]
   714 E C0205251:low [Qualitative Concept]
   714 E C1299352:Low [Qualitative Concept]
   714 E C1550472:low [Idea or Concept]

Phrase: "in men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]

Phrase: "in the general population."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683971:General Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.124: In contrast, another study found that women with Down's syndrome were approximately twice as likely to develop dementia as men (Lai et al, 1999) (see Fig. 3b). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "another study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that women with Down's syndrome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0043210:Women [Population Group]

Phrase: "were"

Phrase: "approximately twice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332232:Approximately [Qualitative Concept]
   861   C1720725:Twice [Intellectual Product]
   861   C1948050:Twice [Quantitative Concept]

Phrase: "as"

Phrase: "likely to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]
   789 E C0033204:Likelihood [Quantitative Concept]

Phrase: "develop"

Phrase: "dementia as men (Lai et al,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "1999"

Phrase: ")"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 3b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.125: In that study, the effect of gender was seen primarily at younger ages. 

Phrase: "In"

Phrase: "that study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the effect of gender"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "primarily at younger ages."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001779:Age [Organism Attribute]
   737   C0332239:Young [Temporal Concept]
Processing 00000000.tx.126: In both studies, gender differences were largest in those with the APOE 3/3 genotype, suggesting that the high risk associated with the presence of the APOE 4 allele can mask gender effects. 

Phrase: "In both studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "gender differences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0036866:gender differences [Organism Attribute]
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "largest in those with the APOE 3/3 genotype,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0443228:Largest [Quantitative Concept]
   706 E C0549177:Large [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the high risk"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0332167:High Risk [Qualitative Concept]
  1000   C3272283:High Risk [Finding]
   861   C0035647:Risk [Qualitative Concept]
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "associated with the presence of the APOE 4 allele"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   782   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   760   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332281:Associated with [Qualitative Concept]
           Associated
   739   C0002085:Allele [Gene or Genome]
   739   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   706 E C0750490:Associate [Idea or Concept]
   706 E C1706221:Associate [Professional or Occupational Group]

Phrase: "can"

Phrase: "mask"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024861:Mask [Medical Device]
  1000   C1538279:MASK [Gene or Genome]
  1000   C1845191:MASK [Gene or Genome]

Phrase: "gender effects."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0079399:Gender [Organism Attribute]
   861   C0804628:Gender [Clinical Attribute]
   861   C1280500:effects [Qualitative Concept]
   861   C1522384:Gender [Organism Attribute]
   827 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.127: The basis for the different results in studies of gender differences is not clear. 

Phrase: "The basis for the different results"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1527178:Basis [Functional Concept]
   753   C1874451:Basis [Pharmacologic Substance]

Phrase: "in studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "of gender differences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0036866:gender differences [Organism Attribute]
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.128: View larger version (12K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.129: 3 Cumulative incidence of dementia in adults with Down's syndrome by gender: (a) based on Schupf et al (1998); 

Phrase: "3 Cumulative incidence of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "in adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001675:Adults [Age Group]
   966 E C1706450:Adult [Human]

Phrase: "with Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "by gender"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: ":"

Phrase: "(a)"

Phrase: "based on Schupf et al (1998"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.130: (b) based on Lai et al (1999), by kind permission of Lippincott Williams & Wilkins.  

Phrase: "(b)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "based on Lai et al (1999"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0443021:Lai [Intellectual Product]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: ")"

Phrase: ","

Phrase: "by kind permission"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0521104:permission [Qualitative Concept]
   861   C1524004:Permission [Intellectual Product]

Phrase: "of Lippincott Williams & Wilkins."
Processing 00000000.tx.131: Only one published study has examined the influence of oestrogen deficiency on age at onset of dementia in women with Down's syndrome (Cosgrave et al, 1999). 

Phrase: "Only one published study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the influence of oestrogen deficiency"

Phrase: "on age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: "of dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "in women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "with Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "(Cosgrave et al,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.132: Menstrual profiles and risk of dementia in 143 women with Down's syndrome were studied. 

Phrase: "Menstrual profiles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]

Phrase: "in 143 women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]

Phrase: "with Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "were"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.133: Twelve women were postmenopausal and diagnosed with dementia. 

Phrase: "Twelve women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]

Phrase: "were"

Phrase: "postmenopausal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232970:postmenopausal [Temporal Concept]

Phrase: "and"

Phrase: "diagnosed with dementia."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0011900:Diagnosed [Finding]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.134: There was a significant relationship between age at menopause and age at onset of dementia in this subsample (r=0.57). 

Phrase: "There"

Phrase: "was"

Phrase: "a significant relationship between age"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "at menopause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025320:Menopause [Physiologic Function]
  1000   C0567312:Menopause [Finding]

Phrase: "and"

Phrase: "age at onset of dementia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   835   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]
   760   C0332162:Onset [Qualitative Concept]

Phrase: "in this subsample"

Phrase: "(r=0.57"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.135: Although the sample size is small, the results are consistent with the hypothesis that higher endogenous oestrogen levels can lower risk of dementia by decreasing A peptide levels and maintaining cholinergic function in critical neuronal populations. 

Phrase: "Although"

Phrase: "the sample size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242618:Sample Size [Quantitative Concept]
   861   C0456389:size [Spatial Concept]

Phrase: "is"

Phrase: "small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with the hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that higher endogenous oestrogen levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0441889:Levels [Qualitative Concept]
   812   C2936882:Estrogen [Pharmacologic Substance]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "can"

Phrase: "lower risk of dementia"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   816   C3272281:Low Risk [Finding]
   816   C3538919:Low Risk [Quantitative Concept]
   770   C0035647:Risk [Qualitative Concept]
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]
   737 E C0205251:low [Qualitative Concept]
   737 E C1299352:Low [Qualitative Concept]
   737 E C1550472:low [Idea or Concept]

Phrase: "by decreasing A peptide levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "maintaining cholinergic function in critical neuronal populations."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]
Processing 00000000.tx.136: If the association between age at menopause and onset of dementia can be confirmed and supporting hormonal data provided, oestrogen replacement therapy might prove to be an important intervention to delay onset of dementia.  

Phrase: "If"

Phrase: "the association between age"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "at menopause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025320:Menopause [Physiologic Function]
  1000   C0567312:Menopause [Finding]

Phrase: "and"

Phrase: "onset of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332162:Onset [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "supporting hormonal data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: ","

Phrase: "oestrogen replacement therapy"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0014935:Estrogen Replacement Therapy [Therapeutic or Preventive Procedure]
           Estrogen Replacement
   913   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]
   901   C0086258:Estrogen Replacement [Therapeutic or Preventive Procedure]
   901   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1363945:Therapy [Finding]
   827   C1555302:Replacement [Idea or Concept]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "might"

Phrase: "prove"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "an important intervention to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0886296:intervention [Health Care Activity]
   827   C1273869:Intervention [Health Care Activity]
   827   C1948041:Intervention [Therapeutic or Preventive Procedure]
   755 E C3274035:INTERVENTIONAL [Research Activity]

Phrase: "delay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205421:Delay [Temporal Concept]

Phrase: "onset of dementia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332162:Onset [Qualitative Concept]
Processing 00000000.tx.137: INDIVIDUAL DIFFERENCES IN A PEPTIDE LEVELS TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER AND OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES IN... 

Phrase: "INDIVIDUAL DIFFERENCES"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0021228:Individual Differences [Mental Process]
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "IN A PEPTIDE LEVELS TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   785   C0079399:Gender [Organism Attribute]
   785   C0804628:Gender [Clinical Attribute]
   785   C1522384:Gender [Organism Attribute]

Phrase: "AND"

Phrase: "OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021228:Individual Differences [Mental Process]
   779   C1705241:*Difference [Quantitative Concept]
   779   C1705242:Difference [Qualitative Concept]
   729 E C0443199:Differential [Qualitative Concept]

Phrase: "IN..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]
Processing 00000000.tx.138: DISCUSSION Clinical Implications and... 

Phrase: "DISCUSSION Clinical Implications"

Phrase: "and..."
Processing 00000000.tx.139: ACKNOWLEDGMENTS REFERENCES  In Down's syndrome, as in Alzheimer's disease, deposition of A1-42 precedes the appearance of A1-40 (Iwatsubo et al, 1995). 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "REFERENCES  In Down's syndrome,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   770   C0039082:Syndrome [Disease or Syndrome]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   715   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   715   C2626739:Lanugo [Eukaryote]

Phrase: "as in Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "deposition of A1-42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333562:Deposition [Functional Concept]

Phrase: "precedes"

Phrase: "the appearance of A1-40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0233426:Appearance [Organism Attribute]
   760   C0700364:Appearance [Qualitative Concept]

Phrase: "(Iwatsubo et al,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.140: A1-42 was the predominant species in the brains of young (age <50 years) individuals with Down's syndrome; 

Phrase: "A1-42"

Phrase: "was"

Phrase: "the predominant species in the brains of young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1705920:Species [Conceptual Entity]

Phrase: "(age <50 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C1510829:Age-Years [Temporal Concept]
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "individuals with Down's syndrome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0027361:Individual [Population Group]
   737   C0237401:Individual [Human]

Phrase: ";"
Processing 00000000.tx.141: A1-40 deposits were observed only a decade or more later. 

Phrase: "A1-40 deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a decade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2981279:Decade [Quantitative Concept]

Phrase: "or"

Phrase: "more later."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205087:Late [Temporal Concept]
Processing 00000000.tx.142: Compared with age-matched controls from the general population, plasma levels of both A1-42 and A1-40 are increased in adults with Down's syndrome (Tokuda et al, 1997; Mehta et al, 1998), but one study found that this increase was not related to dementia status (Tokuda et al, 1997). 

Phrase: "Compared with age-matched controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0001779:Age [Organism Attribute]
   760   C0150103:matched [Research Activity]
   760   C1707455:Compared [Activity]
   760   C1708943:Matched [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "from the general population,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683971:General Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "plasma levels of both A1-42"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0032105:Plasma [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "are"

Phrase: "increased in adults"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0001675:Adults [Age Group]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   756 E C1706450:Adult [Human]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "with Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "(Tokuda et al,"

Phrase: "1997"

Phrase: "; Mehta et al,"

Phrase: "1998"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "one study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "this increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "related to dementia status"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C0449438:Status [Qualitative Concept]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "(Tokuda et al,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.143: Our group studied plasma A1-42 and A1-40 levels in 108 adults with Down's syndrome with and without dementia and compared them with plasma levels in 64 adults without dementia from the general population (Schupf et al, 2001). 

Phrase: "Our group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "plasma A1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "and"

Phrase: "A1-40 levels in 108 adults"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "with Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "with"

Phrase: "and without dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]
   790   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "them with plasma levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0032105:Plasma [Body Substance]
   770   C0441889:Levels [Qualitative Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in 64 adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001675:Adults [Age Group]
   827 E C1706450:Adult [Human]

Phrase: "without dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "from the general population"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683971:General Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "(Schupf et al,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.144: A1-42 and A1-40 levels were significantly higher in the adults with Down's syndrome than in controls from the general population (P=0.0001), and highest in adults with dementia and Down's syndrome, mean plasma levels of A1-42, but not A1-40, were higher in individuals with the APOE 4 allele than in those without an 4 allele, regardless of dementia status (see Fig. 4). 

Phrase: "A1-42"

Phrase: "and"

Phrase: "A1-40 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly higher in the adults"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "with Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "than"

Phrase: "in controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "from the general population"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683971:General Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "(P=0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "highest in adults"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   790   C1522410:Highest [Qualitative Concept]
   756 E C0205250:High [Qualitative Concept]
   756 E C1299351:High [Qualitative Concept]
   756 E C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "with dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "Down's syndrome,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "mean plasma levels of A1-42,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0032105:Plasma [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "but"

Phrase: "not A1-40,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439509:/40 [Temporal Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "were"

Phrase: "higher in individuals"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "with the APOE 4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "than"

Phrase: "in those without an 4 allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "regardless of dementia status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449438:Status [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.145: The effect of the APOE 4 allele on A1-42 levels may be related to acceleration of the rate of amyloid fibril formation (Ma et al, 1994) or diminished clearance of A (McNamara et al, 1998). 

Phrase: "The effect of the APOE 4 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on A1-42 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "related to acceleration of the rate of amyloid fibril formation"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   782   C3544412:amyloid fibril formation [Molecular Function]
   739   C0000894:Acceleration [Phenomenon or Process]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0220781:formation [Biologic Function]
   739   C0225328:Fibril [Cell Component]
   739   C0439634:formation [Spatial Concept]
   739   C0439849:Related [Qualitative Concept]
   739   C0445223:Related [Finding]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0871208:Rate [Activity]
   739   C1521828:Rate [Quantitative Concept]
   739   C1522492:Formation [Functional Concept]
   739   C1948066:Fibril [Physical Object]
   706 E C0163712:Relate [Organic Chemical]

Phrase: "(Ma et al,"

Phrase: "1994"

Phrase: ")"

Phrase: "or"

Phrase: "diminished clearance of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "(McNamara et al,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.146: View larger version (9K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(9K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.147: 4 Plasma levels of A1-42 and A1-40 in adults with Down's syndrome with and without dementia by APOE genotype. 

Phrase: "4 Plasma levels of A1-42"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   783   C0456950:4 levels [Qualitative Concept]
   753   C0032105:Plasma [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "A1-40 in adults"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0001675:Adults [Age Group]
   770   C0439509:/40 [Temporal Concept]
   737 E C1706450:Adult [Human]

Phrase: "with Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "with"

Phrase: "and without dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]
   790   C1515981:And [Idea or Concept]

Phrase: "by APOE genotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.148: , any 4 allele; 

Phrase: ","

Phrase: "any 4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.149: , no 4 allele. 

Phrase: ","

Phrase: "no 4 allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.150: From Schupf et al, 2001, with permission from Elsevier Science.   

Phrase: "From Schupf et al,"

Phrase: "2001,"

Phrase: "with permission"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0521104:permission [Qualitative Concept]
  1000   C1524004:Permission [Intellectual Product]

Phrase: "from Elsevier Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.151: DISCUSSION TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER AND OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES IN... 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   786   C0079399:Gender [Organism Attribute]
   786   C0804628:Gender [Clinical Attribute]
   786   C1522384:Gender [Organism Attribute]

Phrase: "AND"

Phrase: "OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021228:Individual Differences [Mental Process]
   779   C1705241:*Difference [Quantitative Concept]
   779   C1705242:Difference [Qualitative Concept]
   729 E C0443199:Differential [Qualitative Concept]

Phrase: "IN..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]
Processing 00000000.tx.152: DISCUSSION Clinical Implications and... 

Phrase: "DISCUSSION Clinical Implications"

Phrase: "and..."
Processing 00000000.tx.153: ACKNOWLEDGMENTS REFERENCES  Factors that influence the formation of A, such as the APOE 4 allele, oestrogen deficiency and high levels of A1-42 peptides, are associated with earlier onset of dementia in Down's syndrome, while factors that decrease the formation of A, such as the APOE 2 allele or atypical karyotypes that reduce APP gene dose, are associated with lower mortality and reduced risk of dementia. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "influence"

Phrase: "the formation of A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "such as the APOE 4 allele,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "oestrogen deficiency"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0853662:estrogen deficiency [Disease or Syndrome]
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: "and"

Phrase: "high levels of A1-42 peptides,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "associated with earlier onset of dementia"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   773   C1833334:Early-onset [Finding]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0332162:Onset [Qualitative Concept]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
   719 E C0750490:Associate [Idea or Concept]
   719   C1279919:Early [Temporal Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in Down's syndrome,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "while"

Phrase: "factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the formation of A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "such as the APOE 2 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0002085:Allele [Gene or Genome]
   756   C0052198:Apolipoprotein E-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "atypical karyotypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022526:karyotypes [Laboratory Procedure]
   861   C0178725:karyotypes [Laboratory or Test Result]
   861   C1261273:Karyotypes [Organism Attribute]

Phrase: "that"

Phrase: "reduce"

Phrase: "APP gene dose,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0178602:Dose [Quantitative Concept]
   804   C0869039:Dose [Quantitative Concept]
   804   C1114758:Dose # [Clinical Attribute]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "are"

Phrase: "associated with lower mortality"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0026565:Mortality [Quantitative Concept]
   770   C0026566:mortality [Quantitative Concept]
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "reduced risk of dementia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.154: An important task for future work will be to identify the sources of individual variation in premorbid A levels. 

Phrase: "An important task for future work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3540678:Task [Occupational Activity]

Phrase: "will"

Phrase: "be"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the sources of individual variation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0449416:sources [Finding]
   726 E C1705919:Source [Idea or Concept]

Phrase: "in premorbid A levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.155: Since 95% of people with Down's syndrome have triplication of APP associated with free trisomy, overexpression of APP cannot account for the differences in age at onset of dementia within this population. 

Phrase: "Since 95% of people"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0027361:People [Population Group]
   770   C1711239:Since [Temporal Concept]

Phrase: "with Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "have"

Phrase: "triplication of APP"

Phrase: "associated with free trisomy,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0041107:Trisomy [Disease or Syndrome]
   770   C0332296:free [Functional Concept]
   770   C1880497:Free [Qualitative Concept]
   770   C1996904:Free [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "overexpression of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "cannot"

Phrase: "account for the differences"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "in age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: "of dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "within this population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]
Processing 00000000.tx.156: Rather, the joint effects of a variety of factors, including those reviewed here and others not yet identified, must influence the development of Alzheimer's disease. 

Phrase: "Rather,"

Phrase: "the joint effects of a variety of factors,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0022417:Joint [Body Space or Junction]
   744   C0392905:Joint, NOS [Body System]
   744   C1269611:Joint [Body Space or Junction]
   744   C1280500:effects [Qualitative Concept]
   744   C1706309:Joint [Medical Device]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "those reviewed here"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0282443:reviewed [Intellectual Product]
   861   C1709940:Reviewed [Qualitative Concept]
   827 E C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "must"

Phrase: "influence"

Phrase: "the development of Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]
Processing 00000000.tx.157: This suggests that we will need to focus on younger adults with Down's syndrome to identify causes of individual differences in lifespan development and to determine when they begin to exert their effects.  

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "we"

Phrase: "will"

Phrase: "need to focus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0027552:Need [Qualitative Concept]
   790   C0205234:Focus [Spatial Concept]
   790   C0686904:need [Functional Concept]
   790   C1285542:focus [Functional Concept]

Phrase: "on younger adults"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0238598:Adults, Young [Age Group]
   861   C0001675:Adults [Age Group]
   827 E C1706450:Adult [Human]

Phrase: "with Down's syndrome to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   827   C0039082:Syndrome [Disease or Syndrome]
   771   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   771   C2626739:Lanugo [Eukaryote]

Phrase: "identify"

Phrase: "causes of individual differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0015127:causes [Functional Concept]
   770   C1314792:Causes [Functional Concept]
   737 E C1524003:Cause [Conceptual Entity]

Phrase: "in lifespan development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "when"

Phrase: "they"

Phrase: "begin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "their effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.158: Clinical Implications and Limitations TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER AND OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES IN... 

Phrase: "Clinical Implications"

Phrase: "and"

Phrase: "Limitations TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   786   C0079399:Gender [Organism Attribute]
   786   C0804628:Gender [Clinical Attribute]
   786   C1522384:Gender [Organism Attribute]

Phrase: "AND"

Phrase: "OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021228:Individual Differences [Mental Process]
   779   C1705241:*Difference [Quantitative Concept]
   779   C1705242:Difference [Qualitative Concept]
   729 E C0443199:Differential [Qualitative Concept]

Phrase: "IN..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]
Processing 00000000.tx.159: DISCUSSION Clinical Implications and... 

Phrase: "DISCUSSION Clinical Implications"

Phrase: "and..."
Processing 00000000.tx.160: ACKNOWLEDGMENTS REFERENCES  CLINICAL IMPLICATIONS Onset of dementia in Down's syndrome is modified by risk factors that influence formation and deposition of beta amyloid, as well as by triplication of the gene for amyloid precursor protein. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "CLINICAL IMPLICATIONS Onset of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332162:Onset [Qualitative Concept]

Phrase: "in Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "is"

Phrase: "modified by risk factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0035648:risk factors [Quantitative Concept]
   833   C0205349:Modified By [Qualitative Concept]
   833   C1553898:risk factors [Idea or Concept]
   770   C0035647:Risk [Qualitative Concept]
   770   C0392747:Modified [Functional Concept]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "influence"

Phrase: "formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "deposition of beta amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0011560:Amyloid deposition [Pathologic Function]
   819   C1705760:Amyloid Deposition [Finding]
   770   C0333562:Deposition [Functional Concept]

Phrase: "as well as by triplication of the gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0017337:Gene [Gene or Genome]
   744   C0205170:Well [Qualitative Concept]
   744   C3146287:Well [Manufactured Object]

Phrase: "for amyloid precursor protein."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.161: Investigation of risk factor profiles should be considered as part of a differential diagnosis of dementia in Down's syndrome. 

Phrase: "Investigation of risk factor profiles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Investigation [Health Care Activity]
   760   C1552578:investigation [Idea or Concept]

Phrase: "should"

Phrase: "be"

Phrase: "considered as part of a differential diagnosis of dementia"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C0011906:Differential Diagnosis [Diagnostic Procedure]
   764   C0220820:differential diagnosis [Functional Concept]
   764   C1292711:Part of [Spatial Concept]
   742   C0011265:dementia [Mental or Behavioral Dysfunction]
   742   C0011900:Diagnosis [Finding]
   742   C0443199:Differential [Qualitative Concept]
   742   C0449719:Part [Spatial Concept]
   742   C0497327:Dementia [Mental or Behavioral Dysfunction]
   742   C0750591:considered [Idea or Concept]
   742   C1704338:diagnosis [Qualitative Concept]
   742   C1704656:DIAGNOSIS [Research Activity]
   742   C1705242:Differential [Qualitative Concept]
   742   C1709471:Part [Quantitative Concept]

Phrase: "in Down's syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.162: Studies of younger adults with Down's syndrome may help to identify causes of individual differences in the development of Alzheimer's disease. 

Phrase: "Studies of younger adults"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "with Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "may"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "causes of individual differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0015127:causes [Functional Concept]
   770   C1314792:Causes [Functional Concept]
   737 E C1524003:Cause [Conceptual Entity]

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.163: LIMITATIONS Reliable and valid cognitive assessment batteries and diagnostic criteria are required to detect dementia in early stages and to improve studies of risk factors. 

Phrase: "LIMITATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449295:limitations [Functional Concept]

Phrase: "Reliable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C2347947:Reliability [Quantitative Concept]

Phrase: "and"

Phrase: "valid cognitive assessment batteries"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0337088:batteries [Manufactured Object]
   779 E C0542351:Battery [Injury or Poisoning]

Phrase: "and"

Phrase: "diagnostic criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679228:diagnostic criteria [Intellectual Product]
   861   C0243161:criteria [Intellectual Product]

Phrase: "are"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "dementia in early stages"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "improve"

Phrase: "studies of risk factors."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]
Processing 00000000.tx.164: Most studies have had small sample sizes and have not controlled for potential confounders and modifiers such as age, gender and level of intellectual disability. 

Phrase: "Most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "had"

Phrase: "small sample sizes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0242618:Sizes, Sample [Quantitative Concept]
   896   C0748864:small size [Finding]
   827   C0456389:SIZES [Spatial Concept]

Phrase: "and"

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "controlled for potential confounders"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C2587213:Controlled [Functional Concept]
   770   C3245505:Potential [Qualitative Concept]
   737 E C0243148:control [Qualitative Concept]
   737 E C1550141:Control [Substance]
   737 E C1882979:Control [Conceptual Entity]
   737 E C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "modifiers such as age,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0205349:Modifier [Qualitative Concept]
   737   C1514623:Modifier [Conceptual Entity]
   737   C1516451:Modifier [Chemical Viewed Functionally]
   737   C3542952:Modifier [Intellectual Product]

Phrase: "gender"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "and"

Phrase: "level of intellectual disability."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.165: Most studies have used prevalent rather than incident cases, which may mask the effect of risk factors for disease onset through confounding with differential survival.  

Phrase: "Most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "used prevalent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   789   C0033105:Prevalence [Quantitative Concept]
   789   C0220900:prevalence [Quantitative Concept]

Phrase: "rather than"

Phrase: "incident cases,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   861   C1551358:incident [Idea or Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "which"

Phrase: "may"

Phrase: "mask"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024861:Mask [Medical Device]
  1000   C1538279:MASK [Gene or Genome]
  1000   C1845191:MASK [Gene or Genome]

Phrase: "the effect of risk factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "for disease onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0277793:disease onset [Temporal Concept]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "through confounding"

Phrase: "with differential survival."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
Processing 00000000.tx.166: ACKNOWLEDGMENTS TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER AND OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES IN... 

Phrase: "ACKNOWLEDGMENTS TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   786   C0079399:Gender [Organism Attribute]
   786   C0804628:Gender [Clinical Attribute]
   786   C1522384:Gender [Organism Attribute]

Phrase: "AND"

Phrase: "OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021228:Individual Differences [Mental Process]
   779   C1705241:*Difference [Quantitative Concept]
   779   C1705242:Difference [Qualitative Concept]
   729 E C0443199:Differential [Qualitative Concept]

Phrase: "IN..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]
Processing 00000000.tx.167: DISCUSSION Clinical Implications and... 

Phrase: "DISCUSSION Clinical Implications"

Phrase: "and..."
Processing 00000000.tx.168: ACKNOWLEDGMENTS REFERENCES  I thank my collaborators on this work: Richard Mayeux, MD, Warren Zigman, PhD, Wayne Silverman, PhD, Benjamin Tycko, MD, Pankaj Mehta, PhD, Edmund Jenkins, PhD, Deborah Pang, MPH, and Bindu Patel, MPH.  

Phrase: "ACKNOWLEDGMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "my collaborators on this work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C2827395:Collaborator [Professional Society]

Phrase: ":"

Phrase: "Richard Mayeux,"

Phrase: "MD,"

Phrase: "Warren Zigman,"

Phrase: "PhD,"

Phrase: "Wayne Silverman,"

Phrase: "PhD,"

Phrase: "Benjamin Tycko,"

Phrase: "MD,"

Phrase: "Pankaj Mehta,"

Phrase: "PhD,"

Phrase: "Edmund Jenkins,"

Phrase: "PhD,"

Phrase: "Deborah Pang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413561:PANG [Gene or Genome]

Phrase: "MPH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1513008:MPH [Intellectual Product]

Phrase: "and"

Phrase: "Bindu Patel,"

Phrase: "MPH."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1513008:MPH [Intellectual Product]
Processing 00000000.tx.169: REFERENCES TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER AND OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES IN... 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION AMYLOID CASCADE HYPOTHESIS ATYPICAL KARYOTYPES GENETIC SUSCEPTIBILITY FACTORS GENDER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   787   C0079399:Gender [Organism Attribute]
   787   C0804628:Gender [Clinical Attribute]
   787   C1522384:Gender [Organism Attribute]

Phrase: "AND"

Phrase: "OESTROGEN DEFICIENCY INDIVIDUAL DIFFERENCES"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0021228:Individual Differences [Mental Process]
   779   C1705241:*Difference [Quantitative Concept]
   779   C1705242:Difference [Qualitative Concept]
   729 E C0443199:Differential [Qualitative Concept]

Phrase: "IN..."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]
Processing 00000000.tx.170: DISCUSSION Clinical Implications and... 

Phrase: "DISCUSSION Clinical Implications"

Phrase: "and..."
Processing 00000000.tx.171: ACKNOWLEDGMENTS REFERENCES  Aylward, E. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Aylward,"

Phrase: "E."
Processing 00000000.tx.172: H., Burt, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Burt,"

Phrase: "D."
Processing 00000000.tx.173: B., Thorpe, L. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Thorpe,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.174: U., et al (1997) Diagnosis of dementia in individuals with intellectual disability. 

Phrase: "U.,"

Phrase: "et al (1997"

Phrase: ")"

Phrase: "Diagnosis of dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011900:Diagnosis [Finding]
   790   C1704338:diagnosis [Qualitative Concept]
   790   C1704656:DIAGNOSIS [Research Activity]

Phrase: "in individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "with intellectual disability."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0025362:Intellectual Disability [Mental or Behavioral Dysfunction]
   861   C0231170:Disability [Finding]
   789 E C0018576:Disabled [Patient or Disabled Group]
   789 E C1880351:Disabled [Qualitative Concept]
Processing 00000000.tx.175: Journal of Intellectual Disability Research, 41, 152-164.[Medline] Bachman, D. 

Phrase: "Journal of Intellectual Disability Research,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "41,"

Phrase: "152-164."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bachman,"

Phrase: "D."
Processing 00000000.tx.176: L., Wolf, P. 

Phrase: "L., Wolf,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325001:Wolf [Mammal]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.177: A., Linn, R. 

Phrase: "A.,"

Phrase: "Linn,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.178: T., et al (1993) Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "et al (1993"

Phrase: ")"

Phrase: "Incidence of dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0021149:Incidence [Quantitative Concept]
   790   C0220856:incidence [Functional Concept]
   718 E C1551358:incident [Idea or Concept]

Phrase: "and"

Phrase: "probable Alzheimer's disease in a general population"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]

Phrase: ":"

Phrase: "the Framingham Study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.179: Neurology, 43, 515-519.[Abstract] Barrett-Conner, E. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "43,"

Phrase: "515-519."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Barrett-Conner,"

Phrase: "E."
Processing 00000000.tx.180: & Kritz-Silverstein, D. 

Phrase: "& Kritz-Silverstein,"

Phrase: "D."
Processing 00000000.tx.181: (1993) Estrogen replacement therapy and cognitive function in older women. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Estrogen replacement therapy"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0014935:Estrogen Replacement Therapy [Therapeutic or Preventive Procedure]
           Estrogen Replacement
   913   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]
   901   C0086258:Estrogen Replacement [Therapeutic or Preventive Procedure]
   901   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1363945:Therapy [Finding]
   827   C1555302:Replacement [Idea or Concept]
   827   C2936882:Estrogen [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "cognitive function in older women."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0392335:cognitive function [Mental Process]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1516691:Cognitive [Functional Concept]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.182: Journal of the American Medical Association, 269, 2637-2641.[Abstract] Benjamin, R., Leake, A., McArthur, F. 

Phrase: "Journal of the American Medical Association,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "269,"

Phrase: "2637-2641."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Benjamin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442989:Benjamin [Intellectual Product]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Leake,"

Phrase: "A.,"

Phrase: "McArthur,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.183: K., et al (1994) Protective effect of apoE 2 in Alzheimer's disease. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "et al (1994"

Phrase: ")"

Phrase: "Protective effect of apoE 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.184: Lancet, 344, 473. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "344,"

Phrase: "473."
Processing 00000000.tx.185: Borchelt, D. 

Phrase: "Borchelt,"

Phrase: "D."
Processing 00000000.tx.186: R., Thinakaran, G., Eckman, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.187: B., et al (1996) Familial Alzheimer's disease-linked presenilin I variants elevate Abetal-42/1-40 ratio in vitro and in vivo. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "et al (1996"

Phrase: ")"

Phrase: "Familial Alzheimer's disease-linked presenilin I variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0205419:variants [Qualitative Concept]

Phrase: "elevate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "Abetal-42/1-40 ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0456603:Ratio [Quantitative Concept]
   804   C1547037:Ratio [Intellectual Product]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.188: Neuron, 17, 1005-1013.[Medline] Brenner, D. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "17,"

Phrase: "1005-1013."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brenner,"

Phrase: "D."
Processing 00000000.tx.189: E., Kukull, W. 

Phrase: "E.,"

Phrase: "Kukull,"

Phrase: "W."
Processing 00000000.tx.190: A., Stergachis, A., et al (1994) Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based casecontrol study. 

Phrase: "A.,"

Phrase: "Stergachis,"

Phrase: "A.,"

Phrase: "et al (1994"

Phrase: ")"

Phrase: "Postmenopausal estrogen replacement therapy"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   923   C0014935:Estrogen Replacement Therapy [Therapeutic or Preventive Procedure]
           Estrogen Replacement
   875   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]
   861   C0086258:Estrogen Replacement [Therapeutic or Preventive Procedure]
   861   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   812   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   812   C0035139:Replacement [Therapeutic or Preventive Procedure]
   812   C0039798:therapy [Functional Concept]
   812   C0087111:Therapy [Therapeutic or Preventive Procedure]
   812   C0559956:Replacement [Functional Concept]
   812   C1363945:Therapy [Finding]
   812   C1555302:Replacement [Idea or Concept]
   812   C2936882:Estrogen [Pharmacologic Substance]
   741 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "the risk of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: ":"

Phrase: "a population-based casecontrol study."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1709599:Population Based Study [Research Activity]
   902   C0681876:Population Study [Research Activity]
   861   C0007328:Case-Control Study [Research Activity]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]
Processing 00000000.tx.191: American Journal of Epidemiology, 140, 262-267.[Abstract] Campbell, W. 

Phrase: "American Journal of Epidemiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "140,"

Phrase: "262-267."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Campbell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331936:Campbell [Health Care Related Organization]

Phrase: "W."
Processing 00000000.tx.192: A., Lowther, J., McKenzie, I., et al (1982) Serum gonadotrophins in Down syndrome. 

Phrase: "A.,"

Phrase: "Lowther,"

Phrase: "J.,"

Phrase: "McKenzie,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "et al (1982"

Phrase: ")"

Phrase: "Serum gonadotrophins in Down syndrome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0018061:Gonadotrophins, NOS [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.193: Journal of Medical Genetics, 19, 98-99.[Medline] Chicoine, B. 

Phrase: "Journal of Medical Genetics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "19,"

Phrase: "98-99."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chicoine,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.194: & McGuire, D. 

Phrase: "& McGuire,"

Phrase: "D."
Processing 00000000.tx.195: (1997) Longevity of a woman with Down syndrome: A case study. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Longevity of a woman"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023980:Longevity [Temporal Concept]

Phrase: "with Down syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: ":"

Phrase: "A case study."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0085973:Case Study [Intellectual Product]
   827   C0557651:Study [Manufactured Object]
   827   C0868928:Case [Functional Concept]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]
   827   C2603343:Study [Research Activity]
Processing 00000000.tx.196: Mental Retardation, 35, 477-479.[Medline] Corder, E. 

Phrase: "Mental Retardation,"
Meta Candidates (Total=10; Excluded=8; Pruned=0; Remaining=2)
  1000   C0025362:Mental Retardation [Mental or Behavioral Dysfunction]
   928 E C0079822:Mentally Retarded [Patient or Disabled Group]
   861   C0229992:mental [Mental Process]
   777 E C0229993:Psychic [Functional Concept]
   761 E C0011980:Diaphragm [Body Part, Organ, or Organ Component]
   761 E C0042241:DIAPHRAGM [Medical Device]
   761 E C1279038:Diaphragm [Body Part, Organ, or Organ Component]
   761 E C1705367:Diaphragm [Medical Device]
   750 E C0086045:mindfulness [Mental Process]
   750 E C3542996:Mindfulness [Mental Process]

Phrase: "35,"

Phrase: "477-479."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Corder,"

Phrase: "E."
Processing 00000000.tx.197: H., Saunders, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A."
Processing 00000000.tx.198: M., Strittmatter, W. 

Phrase: "M."

Phrase: ","

Phrase: "Strittmatter,"

Phrase: "W."
Processing 00000000.tx.199: J., et al (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. 

Phrase: "J.,"

Phrase: "et al (1993"

Phrase: ")"

Phrase: "Gene dose of apolipoprotein E type 4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0178602:Dose [Quantitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C1114758:Dose # [Clinical Attribute]

Phrase: "and"

Phrase: "the risk of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "in late onset families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.200: Science, 261, 921-923.[Medline] Corder, E. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "261,"

Phrase: "921-923."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Corder,"

Phrase: "E."
Processing 00000000.tx.201: H., Saunders, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A."
Processing 00000000.tx.202: M., Risch, N. 

Phrase: "M."

Phrase: ","

Phrase: "Risch,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.203: J., et al (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease. 

Phrase: "J.,"

Phrase: "et al (1994"

Phrase: ")"

Phrase: "Protective effect of apolipoprotein E type 2 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "for late onset Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.204: Nature Genetics, 7, 180-184.[Medline] Cosgrave, M. 

Phrase: "Nature Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: "7,"

Phrase: "180-184."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cosgrave,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.205: P., Tyrrell, J., Dreja, H., et al (1996) Lower frequency of apolipoprotein E4 allele in an elderly Down's syndrome population. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Tyrrell,"

Phrase: "J.,"

Phrase: "Dreja,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "et al (1996"

Phrase: ")"

Phrase: "Lower frequency of apolipoprotein E4 allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0017270:Allele Frequency [Quantitative Concept]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "in an elderly Down's syndrome population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032659:Population [Quantitative Concept]
   812   C1257890:Population [Population Group]
Processing 00000000.tx.206: Biological Psychiatry, 40, 811-813.[CrossRef][Medline] Cosgrave, M. 

Phrase: "Biological Psychiatry,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0005523:Biological Psychiatry [Biomedical Occupation or Discipline]
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0033872:Psychiatry [Professional or Occupational Group]
   861   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   861   C0205460:biological [Qualitative Concept]
   789 E C0205487:Psychiatric [Functional Concept]

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "811-813."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cosgrave,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.207: P., Tyrell, J., McCarron, M., et al (1999) Age at onset of dementia and age of menopause in women with Down's syndrome. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Tyrell,"

Phrase: "J.,"

Phrase: "McCarron,"

Phrase: "M."

Phrase: ","

Phrase: "et al (1999"

Phrase: ")"

Phrase: "Age at onset of dementia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   835   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]
   760   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "age of menopause"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001779:Age [Organism Attribute]

Phrase: "in women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "with Down's syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.208: Journal of Intellectual Disability Research, 43, 461-465.[CrossRef][Medline] Cummings, B. 

Phrase: "Journal of Intellectual Disability Research,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "43,"

Phrase: "461-465."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cummings,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.209: & Cotman, C. 

Phrase: "& Cotman,"

Phrase: "C."
Processing 00000000.tx.210: (1995) Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Image analysis of beta-amyloid load"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0200765:Image analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1704254:Image [Intellectual Product]
   753   C1704922:Image [Entity]
   753   C3542466:Image [Intellectual Product]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "relation to dementia severity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0080103:Relation [Family Group]
   770   C0869014:relation [Social Behavior]
Processing 00000000.tx.211: Lancet, 346, 1524-1528.[CrossRef][Medline] Deb, S., Braganza, J. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "346,"

Phrase: "1524-1528."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Deb,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0059541:DEB [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "S."

Phrase: ","

Phrase: "Braganza,"

Phrase: "J."
Processing 00000000.tx.212: & Norton, N. 

Phrase: "& Norton,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.213: (2000) APOE 4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome. 

Phrase: "(2000"

Phrase: ")"

Phrase: "APOE 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "influences"

Phrase: "the manifestation of Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1280464:Manifestation of [Qualitative Concept]
           manifestation
   760   C0205319:manifestation [Functional Concept]

Phrase: "in adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001675:Adults [Age Group]
   966 E C1706450:Adult [Human]

Phrase: "with Down's syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.214: British Journal of Psychiatry, 176, 468-472.[Abstract/Free FullText] Farrer, M. 

Phrase: "British Journal of Psychiatry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "176,"

Phrase: "468-472."

Phrase: "[Abstract/Free FullText"

Phrase: "] Farrer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.215: J., Crayton, L., Davies, G. 

Phrase: "J.,"

Phrase: "Crayton,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Davies,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.216: E., et al (1997) Allelic variability in D21S11, but not in APP or APOE, is associated with cognitive decline in Down syndrome. 

Phrase: "E.,"

Phrase: "et al (1997"

Phrase: ")"

Phrase: "Allelic variability in D21S11,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2827666:Variability [Conceptual Entity]

Phrase: "but"

Phrase: "not in APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1518422:Not [Functional Concept]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "or"

Phrase: "APOE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "associated with cognitive decline"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
   770   C1516691:Cognitive [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in Down syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.217: Neuroreport, 8, 1645-1649.[Medline] Goate, A., Chartier-Harlin, M. 

Phrase: "Neuroreport,"

Phrase: "8,"

Phrase: "1645-1649."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Goate,"

Phrase: "A.,"

Phrase: "Chartier-Harlin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.218: C., Mullan, M., et al (1991) Segregation of a missense mutation of the amyloid precursor protein gene with familial Alzheimer's disease. 

Phrase: "C., Mullan,"

Phrase: "M."

Phrase: ","

Phrase: "et al (1991"

Phrase: ")"

Phrase: "Segregation of a missense mutation of the amyloid precursor protein gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0080141:segregation [Social Behavior]

Phrase: "with familial Alzheimer's disease."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.219: Nature, 349, 704-706.[CrossRef][Medline] Goodman, Y., Bruce, A. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "349,"

Phrase: "704-706."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Goodman,"

Phrase: "Y.,"

Phrase: "Bruce,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332417:BRUCE [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.220: J., Cheng, B., et al (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. 

Phrase: "J.,"

Phrase: "Cheng,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "et al (1996"

Phrase: ")"

Phrase: "Estrogens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0014939:Estrogens [Hormone,Pharmacologic Substance,Steroid]
   966 E C2936882:Estrogen [Pharmacologic Substance]
   916 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "attenuate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "and"

Phrase: "corticosterone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010124:Corticosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "exacerbates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0436331:exacerbate [Finding]

Phrase: "excitotoxicity,"

Phrase: "oxidative injury,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "and"

Phrase: "amyloid beta-peptide toxicity in hippocampal neurons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0040539:toxicity [Qualitative Concept]
   748   C0600688:Toxicity [Injury or Poisoning]
Processing 00000000.tx.221: Journal of Neurochemistry, 66, 1836-1844.[Medline] Hardy, J., Crook, R., Perry, R., et al (1994) ApoE genotype and Down's syndrome. 

Phrase: "Journal of Neurochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "66,"

Phrase: "1836-1844."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hardy,"

Phrase: "J.,"

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Perry,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "et al (1994"

Phrase: ")"

Phrase: "ApoE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "Down's syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.222: Lancet, 343, 979-980.[Medline] Hasen, J., Boyar, R. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "343,"

Phrase: "979-980."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hasen,"

Phrase: "J.,"

Phrase: "Boyar,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.223: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.224: & Shapiro, L. 

Phrase: "& Shapiro,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.225: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.226: (1980) Gonadal function in trisomy 21. 

Phrase: "(1980"

Phrase: ")"

Phrase: "Gonadal function in trisomy 21."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0018067:Gonadal [Body Part, Organ, or Organ Component]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.227: Hormone Research, 12, 345-350.[Medline] Henderson, V. 

Phrase: "Hormone Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "12,"

Phrase: "345-350."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Henderson,"

Phrase: "V."
Processing 00000000.tx.228: W., Paganini-Hill, A., Emmanuel, C. 

Phrase: "W., Paganini-Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442532:Hill [Spatial Concept]

Phrase: "A.,"

Phrase: "Emmanuel,"

Phrase: "C."
Processing 00000000.tx.229: K., et al (1994) Estrogen replacement therapy in older women. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "et al (1994"

Phrase: ")"

Phrase: "Estrogen replacement therapy in older women."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0014935:Estrogen Replacement Therapy [Therapeutic or Preventive Procedure]
           Estrogen Replacement
   790   C0086258:Estrogen Replacement [Therapeutic or Preventive Procedure]
   790   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   783   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]
   753   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   753   C0035139:Replacement [Therapeutic or Preventive Procedure]
   753   C0039798:therapy [Functional Concept]
   753   C0087111:Therapy [Therapeutic or Preventive Procedure]
   753   C0559956:Replacement [Functional Concept]
   753   C1363945:Therapy [Finding]
   753   C1555302:Replacement [Idea or Concept]
   753   C2936882:Estrogen [Pharmacologic Substance]
Processing 00000000.tx.230: Archives of Neurology, 51, 896-900.[Abstract] Henderson, V. 

Phrase: "Archives of Neurology,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0003738:Archives [Manufactured Object]
   790   C0027855:Neurology [Biomedical Occupation or Discipline]
   790   C1554162:Archive [Idea or Concept]
   718 E C0205494:Neurologic [Qualitative Concept]
   718 E C2707261:Neurological [Clinical Attribute]

Phrase: "51,"

Phrase: "896-900."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Henderson,"

Phrase: "V."
Processing 00000000.tx.231: W., Paganini-Hill, A., Miller, B. 

Phrase: "W., Paganini-Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442532:Hill [Spatial Concept]

Phrase: "A.,"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.232: K., et al (2000) Estrogen for Alzheimer's disease in women: randomized, double-blind placebo-controlled trial. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "et al (2000"

Phrase: ")"

Phrase: "Estrogen for Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   770   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "in women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: ":"

Phrase: "randomized, double-blind placebo-controlled trial."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   904   C0282440:randomized controlled trial [Intellectual Product,Research Activity]
   904   C1096777:Randomized Controlled Trial [Intellectual Product,Research Activity]
   799   C0008976:Trial [Research Activity]
Processing 00000000.tx.233: Neurology, 54, 295-301.[Abstract/Free FullText] Hestnes, A., Stovener, L. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "54,"

Phrase: "295-301."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hestnes,"

Phrase: "A.,"

Phrase: "Stovener,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.234: J., Husoy, O., et al (1991) Hormonal and biochemical disturbances in Down's syndrome. 

Phrase: "J.,"

Phrase: "Husoy,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "et al (1991"

Phrase: ")"

Phrase: "Hormonal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "biochemical disturbances in Down's syndrome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C2699787:Disturbance [Qualitative Concept]
Processing 00000000.tx.235: Journal of Mental Deficiency Research, 35, 179-193.[Medline] Higuchi, S., Muramatsu, T., Matsushita, S., et al (1996) Presenilin-1 polymorphism and Alzheimer's disease. 

Phrase: "Journal of Mental Deficiency Research,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "35,"

Phrase: "179-193."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Higuchi,"

Phrase: "S."

Phrase: ","

Phrase: "Muramatsu,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Matsushita,"

Phrase: "S."

Phrase: ","

Phrase: "et al (1996"

Phrase: ")"

Phrase: "Presenilin-1 polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.236: Lancet, 347, 1186.[Medline] Holland, A. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "347,"

Phrase: "1186."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Holland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027778:Holland [Geographic Area]

Phrase: "A."
Processing 00000000.tx.237: J., Hon, J., Huppert, F. 

Phrase: "J.,"

Phrase: "Hon,"

Phrase: "J.,"

Phrase: "Huppert,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.238: A., et al (1998) Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome. 

Phrase: "A.,"

Phrase: "et al (1998"

Phrase: ")"

Phrase: "Population-based study of the prevalence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1709599:Population Based Study [Research Activity]
   783   C0033106:Study, Prevalence [Quantitative Concept]
   783   C0681876:Population Study [Research Activity]
   783   C2348561:Study Population [Population Group]
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "presentation of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0449450:Presentation [Idea or Concept]

Phrase: "in adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001675:Adults [Age Group]
   966 E C1706450:Adult [Human]

Phrase: "with Down's syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.239: British Journal of Psychiatry, 172, 493-498.[Abstract] Hsiang, Y-H. 

Phrase: "British Journal of Psychiatry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "172,"

Phrase: "493-498."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hsiang,"

Phrase: "Y-H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.240: H., Berkovitz, G. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Berkovitz,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.241: D., Bland, G. 

Phrase: "D."

Phrase: ","

Phrase: "Bland,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.242: L., et al (1987) Gonadal function in patients with Down syndrome. 

Phrase: "L., et al (1987"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0439394:l's [Quantitative Concept]
   812   C1706495:L- [Intellectual Product]
   812   C3642217:/L [Quantitative Concept]

Phrase: ")"

Phrase: "Gonadal function in patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0018067:Gonadal [Body Part, Organ, or Organ Component]
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "with Down syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.243: American Journal of Medical Genetics, 27, 449-458.[Medline] Hyman, B. 

Phrase: "American Journal of Medical Genetics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "27,"

Phrase: "449-458."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.244: T., West, H. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:West [Spatial Concept]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.245: L., Rebeck, G. 

Phrase: "L., Rebeck,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.246: W., et al (1995) Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). 

Phrase: "W., et al (1995"

Phrase: ")"

Phrase: "Quantitative analysis of senile plaques"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0392762:Quantitative [Quantitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "observation of log-normal size distribution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0302523:Observation [Research Activity]
   753   C0700325:observation [Health Care Activity]
   753   C1964257:Observation [Diagnostic Procedure]

Phrase: "and"

Phrase: "molecular epidemiology of differences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0206173:Molecular Epidemiology [Biomedical Occupation or Discipline]
   770   C0014507:Epidemiology [Biomedical Occupation or Discipline]
   770   C0014508:epidemiology [Functional Concept]
   770   C0699910:epidemiology [Health Care Activity]

Phrase: "associated with apolipoprotein E genotype"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0017431:Genotype [Organism Attribute]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "trisomy 21"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013080:Trisomy 21 [Congenital Abnormality,Disease or Syndrome]
  1000   C3537167:Trisomy 21 [Cell or Molecular Dysfunction]
   861   C0041107:Trisomy [Disease or Syndrome]

Phrase: "(Down syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: ")."
Processing 00000000.tx.247: Proceedings of the National Academy of Science USA, 92, 3586-3590.[Abstract] Iwatsubo, T., Odaka, A., Suzuki, N., et al (1994) Visualization of AB42(43) and AB40 in senile plaques with end-specific AB monoclonals: evidence that an initially deposited species is AB42(43). 

Phrase: "Proceedings of the National Academy of Science USA,"

Phrase: "92,"

Phrase: "3586-3590."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Odaka,"

Phrase: "A.,"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "et al (1994"

Phrase: ")"

Phrase: "Visualization of AB42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0175631:Visualization [Mental Process]
   790   C2827662:Visualization [Occupation or Discipline]

Phrase: "(43"

Phrase: ")"

Phrase: "and"

Phrase: "AB40 in senile plaques"

Phrase: "with end-specific AB monoclonals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0746619:monoclonal [Finding]

Phrase: ":"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "an initially deposited species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "is"

Phrase: "AB42"

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.248: Neuron, 13, 45-53.[Medline] Iwatsubo, T., Mann, D. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "13,"

Phrase: "45-53."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mann,"

Phrase: "D."
Processing 00000000.tx.249: M., Odaka, A., et al (1995) Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome. 

Phrase: "M."

Phrase: ","

Phrase: "Odaka,"

Phrase: "A.,"

Phrase: "et al (1995"

Phrase: ")"

Phrase: "Amyloid beta protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C1750295:beta protein [Genetic Function]
   901   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "(A beta"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2004068:Beta [Qualitative Concept]

Phrase: ")"

Phrase: "deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposition [Functional Concept]

Phrase: ":"

Phrase: "A beta 42"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C2827504:Amyloid Beta 42 [Laboratory Procedure]
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "(43"

Phrase: ")"

Phrase: "precedes"

Phrase: "A beta 40 in Down syndrome."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C3641227:Amyloid Beta 40 [Laboratory Procedure]
   790   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   790   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   783 E C2825879:Amyloid, Beta [Laboratory Procedure]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0039082:Syndrome [Disease or Syndrome]
   753   C0330390:Beta [Plant]
   753   C0439096:Beta [Intellectual Product]
   753   C0439509:/40 [Temporal Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C2004068:Beta [Qualitative Concept]
Processing 00000000.tx.250: Annals of Neurology, 37, 294-299.[Medline] Jaffe, A., Toran-Allerand, C. 

Phrase: "Annals of Neurology,"

Phrase: "37,"

Phrase: "294-299."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jaffe,"

Phrase: "A.,"

Phrase: "Toran-Allerand,"

Phrase: "C."
Processing 00000000.tx.251: D., Greengard, P., et al (1994) Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. 

Phrase: "D."

Phrase: ","

Phrase: "Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "et al (1994"

Phrase: ")"

Phrase: "Estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "regulates"

Phrase: "metabolism of Alzheimer amyloid beta precursor protein."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   831   C1327340:amyloid precursor protein metabolism [Molecular Function]
   800   C1327339:beta-amyloid metabolism [Molecular Function]
   774   C0597299:Protein Metabolism [Molecular Function]
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.252: Journal of Biological Chemistry, 269, 13065-13068.[Abstract/Free FullText] Kehoe, P., Williams, J., Lovestone, S., et al (1996) Presenilin-1 polymorphism and Alzheimer's disease. 

Phrase: "Journal of Biological Chemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "269,"

Phrase: "13065-13068."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kehoe,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Williams,"

Phrase: "J.,"

Phrase: "Lovestone,"

Phrase: "S."

Phrase: ","

Phrase: "et al (1996"

Phrase: ")"

Phrase: "Presenilin-1 polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.253: The UK Alzheimer's Disease Collaborative Group. 

Phrase: "The UK Alzheimer's Disease Collaborative Group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
Processing 00000000.tx.254: Lancet, 347, 1185.[CrossRef][Medline] Kosaka, T., Imagawa, M., Seki, K., et al (1997) The beta APP717 Alzheimer mutation increases the percentage of plasma amyloid-beta protein ending at A beta 42(43). 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "347,"

Phrase: "1185."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kosaka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Imagawa,"

Phrase: "M."

Phrase: ","

Phrase: "Seki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272348:Seki [Organic Chemical,Pharmacologic Substance]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "et al (1997"

Phrase: ")"

Phrase: "The beta APP717 Alzheimer mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the percentage of plasma amyloid-beta protein ending"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0439165:Percentage [Quantitative Concept]
   744   C1549488:Percentage [Idea or Concept]
   744   C1561533:Percentage [Idea or Concept]

Phrase: "at A beta 42"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C2827504:Amyloid Beta 42 [Laboratory Procedure]
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.255: Neurology, 48, 741-745.[Abstract] Lai, F. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "48,"

Phrase: "741-745."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443021:Lai [Intellectual Product]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.256: & Williams, R. 

Phrase: "& Williams,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.257: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.258: (1989) A prospective study of Alzheimer disease in Down syndrome. 

Phrase: "(1989"

Phrase: ")"

Phrase: "A prospective study of Alzheimer disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0033522:prospective study [Research Activity]
   790   C1709709:Prospective Study [Research Activity]
   753   C0023981:prospective [Research Activity]
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "in Down syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.259: Archives of Neurology, 46, 849-853.[Abstract] Lai, F., Kamman, E., Rebeck, G. 

Phrase: "Archives of Neurology,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0003738:Archives [Manufactured Object]
   790   C0027855:Neurology [Biomedical Occupation or Discipline]
   790   C1554162:Archive [Idea or Concept]
   718 E C0205494:Neurologic [Qualitative Concept]
   718 E C2707261:Neurological [Clinical Attribute]

Phrase: "46,"

Phrase: "849-853."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443021:Lai [Intellectual Product]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kamman,"

Phrase: "E.,"

Phrase: "Rebeck,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.260: W., et al (1999) APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome. 

Phrase: "W., et al (1999"

Phrase: ")"

Phrase: "APOE genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "gender effects on Alzheimer disease"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0079399:Gender [Organism Attribute]
   760   C0804628:Gender [Clinical Attribute]
   760   C1280500:effects [Qualitative Concept]
   760   C1522384:Gender [Organism Attribute]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "in 100 adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001675:Adults [Age Group]
   827 E C1706450:Adult [Human]

Phrase: "with Down syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.261: Neurology, 53, 331-336.[Abstract/Free FullText] Lambert, J. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "53,"

Phrase: "331-336."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.262: C., Perez-Tur, J., Dupire, M. 

Phrase: "C., Perez-Tur,"

Phrase: "J.,"

Phrase: "Dupire,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.263: J., et al (1996) Analysis of the APOE alleles' impact in Down's syndrome. 

Phrase: "J.,"

Phrase: "et al (1996"

Phrase: ")"

Phrase: "Analysis of the APOE alleles' impact"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "in Down's syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.264: Neuroscience Letters, 220, 57-60.[CrossRef][Medline] Levy-Lehad, E., Wasco, W., Pookaj, P., et al (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. 

Phrase: "Neuroscience Letters,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0282413:letters [Intellectual Product]
   827 E C1096774:Letter [Intellectual Product]
   827 E C2360551:Letter [Clinical Attribute]
   789 E C0079691:Levothyroxine Sodium [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   768 E C0728762:Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "220,"

Phrase: "57-60."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Levy-Lehad,"

Phrase: "E.,"

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Pookaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "et al (1995"

Phrase: ")"

Phrase: "Candidate gene for the chromosome 1 familial Alzheimer's disease locus."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   775   C1332838:Candidate Disease Gene [Gene or Genome]
           Candidate Gene
   757   C1708726:Gene Locus [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   730   C1416989:MAL gene [Gene or Genome]
   722   C1517488:Gene Family [Gene or Genome]
Processing 00000000.tx.265: Science, 269, 973-977.[Medline] Lippa, C. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "269,"

Phrase: "973-977."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lippa,"

Phrase: "C."
Processing 00000000.tx.266: F., Smith, T. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.267: W., Saunders, A. 

Phrase: "W., Saunders,"

Phrase: "A."
Processing 00000000.tx.268: M., et al (1997) Apolipoprotein E-2 and Alzheimer's disease: genotype influences pathologic phenotype. 

Phrase: "M."

Phrase: ","

Phrase: "et al (1997"

Phrase: ")"

Phrase: "Apolipoprotein E-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0052198:Apolipoprotein E-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "influences"

Phrase: "pathologic phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.269: Neurology, 48, 515-519.[Abstract] Ma, J., Yee, A., Brewer, H. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "48,"

Phrase: "515-519."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ma,"

Phrase: "J.,"

Phrase: "Yee,"

Phrase: "A.,"

Phrase: "Brewer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402217:Brewer [Professional or Occupational Group]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.270: B., Jr, et al (1994) Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "et al (1994"

Phrase: ")"

Phrase: "Amyloid-associated proteins alpha 1-antichymotrypsin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0002190:alpha 1-Antichymotrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1412050:ANTICHYMOTRYPSIN, ALPHA-1 [Gene or Genome]
   827   C1879647:Alpha1 [Qualitative Concept]
   827   C1979844:Alpha 1 [Amino Acid, Peptide, or Protein]
   799   C0439095:Alpha [Intellectual Product]
   799   C0443619:Antichymotrypsin [Amino Acid, Peptide, or Protein]
   799   C2003941:Alpha [Intellectual Product]
   799   C2350010:Alpha [Qualitative Concept]

Phrase: "and"

Phrase: "apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "assembly of Alzheimer beta-protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1706853:Assembly [Activity]
   760   C1879748:Assembly [Manufactured Object]

Phrase: "into filaments."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]
Processing 00000000.tx.271: Nature, 372, 92-94.[CrossRef][Medline] Mann, D. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "372,"

Phrase: "92-94."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mann,"

Phrase: "D."
Processing 00000000.tx.272: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.273: (1988) Association between Alzheimer disease and Down syndrome. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Association between Alzheimer disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C1511978:Disease Association [Temporal Concept]
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "Down syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.274: In Alzheimer Disease, Down Syndrome and their Relationship (eds J. Berg, H. Karlinsky & A. Holland), pp. 

Phrase: "In Alzheimer Disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "Down Syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "and"

Phrase: "their Relationship"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439849:Relationship [Qualitative Concept]
  1000   C1705630:Relationship [Idea or Concept]
  1000   C1706279:Relationship [Idea or Concept]
  1000   C3540605:Relationship [Intellectual Product]

Phrase: "(eds J. Berg,"

Phrase: "H. Karlinsky & A. Holland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0027778:Holland [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.275: 71-92. 

Phrase: "71-92."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]
Processing 00000000.tx.276: Oxford: Oxford University Press. 

Phrase: "Oxford"

Phrase: ":"

Phrase: "Oxford University Press."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]
Processing 00000000.tx.277: Mann, D. 

Phrase: "Mann,"

Phrase: "D."
Processing 00000000.tx.278: M., Iwatsubo, T., Ihara, Y., et al (1996) Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. 

Phrase: "M."

Phrase: ","

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ihara,"

Phrase: "Y.,"

Phrase: "et al (1996"

Phrase: ")"

Phrase: "Predominant deposition of amyloid-beta 42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0011560:Amyloid deposition [Pathologic Function]
   783   C1705760:Amyloid Deposition [Finding]
   753   C0333562:Deposition [Functional Concept]

Phrase: "(43"

Phrase: ")"

Phrase: "in plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "in cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "hereditary cerebral hemorrhage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C2937358:Cerebral Hemorrhage [Pathologic Function]
   827   C0019080:Haemorrhage [Pathologic Function]
   827   C0439660:Hereditary [Functional Concept]

Phrase: "associated with mutations"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0026882:Mutations [Genetic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the amyloid precursor protein gene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.279: American Journal of Pathology, 148, 1257-1266.[Abstract] Martins, R. 

Phrase: "American Journal of Pathology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "148,"

Phrase: "1257-1266."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Martins,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.280: N., Clarnette, R., Fisher, C., et al (1995) ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome. 

Phrase: "N., Clarnette,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Fisher,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "et al (1995"

Phrase: ")"

Phrase: "ApoE genotypes in Australia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017431:Genotypes [Organism Attribute]

Phrase: ":"

Phrase: "roles in early"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0035820:Roles [Social Behavior]
   756 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "late onset Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Down's syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.281: Neuroreport, 6, 1513-1516.[Medline] Mayeux, R., Stern, Y., Ottman, R., et al (1993) The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. 

Phrase: "Neuroreport,"

Phrase: "6,"

Phrase: "1513-1516."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mayeux,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stern,"

Phrase: "Y.,"

Phrase: "Ottman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "et al (1993"

Phrase: ")"

Phrase: "The apolipoprotein epsilon 4 allele in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0002085:Allele [Gene or Genome]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.282: Annals of Neurology, 34, 752-754.[Medline] Mayeux, R., Tang, M. 

Phrase: "Annals of Neurology,"

Phrase: "34,"

Phrase: "752-754."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mayeux,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tang,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.283: X., Jacobs, D. 

Phrase: "X.,"

Phrase: "Jacobs,"

Phrase: "D."
Processing 00000000.tx.284: M., et al (1999) Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease. 

Phrase: "M."

Phrase: ","

Phrase: "et al (1999"

Phrase: ")"

Phrase: "Plasma amyloid beta-peptide 1-42"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   895   C2827504:Amyloid Beta 1-42 [Laboratory Procedure]
           Amyloid Beta 42
   861   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   827   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   799   C0032105:Plasma [Body Substance]
   799   C0330390:Beta [Plant]
   799   C0439096:Beta [Intellectual Product]
   799   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   799   C2004068:Beta [Qualitative Concept]

Phrase: "and"

Phrase: "incipient Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.285: Annals of Neurology, 46, 412-416.[CrossRef][Medline] McNamara, M. 

Phrase: "Annals of Neurology,"

Phrase: "46,"

Phrase: "412-416."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McNamara,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.286: J., Gomez-Isla, T. 

Phrase: "J.,"

Phrase: "Gomez-Isla,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.287: & Hyman, B. 

Phrase: "& Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.288: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.289: (1998) Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Apolipoprotein E genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "deposits of Abeta40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0333562:Deposit [Functional Concept]

Phrase: "and"

Phrase: "Abeta42 in Alzheimer disease."
Processing 00000000.tx.290: Archives of Neurology, 55, 1001-1004.[Abstract/Free FullText] Mehta, P. 

Phrase: "Archives of Neurology,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0003738:Archives [Manufactured Object]
   790   C0027855:Neurology [Biomedical Occupation or Discipline]
   790   C1554162:Archive [Idea or Concept]
   718 E C0205494:Neurologic [Qualitative Concept]
   718 E C2707261:Neurological [Clinical Attribute]

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "1001-1004."

Phrase: "[Abstract/Free FullText"

Phrase: "] Mehta,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.291: D., Dalton, A. 

Phrase: "D."

Phrase: ","

Phrase: "Dalton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678223:dalton [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.292: J., Mehta, S. 

Phrase: "J.,"

Phrase: "Mehta,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.293: P., et al (1998) Increased plasma amyloid beta protein 1-42 levels in Down syndrome. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "et al (1998"

Phrase: ")"

Phrase: "Increased plasma amyloid beta protein 1-42 levels in Down syndrome."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   738   C0441889:Levels [Qualitative Concept]
   737   C0428479:Protein level [Laboratory or Test Result]
   737   C0456947:Level 1 [Intellectual Product]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.294: Neuroscience Letters, 241, 13-16.[CrossRef][Medline] Meyer, M. 

Phrase: "Neuroscience Letters,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0282413:letters [Intellectual Product]
   827 E C1096774:Letter [Intellectual Product]
   827 E C2360551:Letter [Clinical Attribute]
   789 E C0079691:Levothyroxine Sodium [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   768 E C0728762:Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "241,"

Phrase: "13-16."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Meyer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.295: R., Tschantz, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tschantz,"

Phrase: "J."
Processing 00000000.tx.296: T., Norten, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Norten,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.297: C., et al (1998) APOE genotype predicts when-not whetherone is predisposed to Alzheimer's disease. 

Phrase: "C., et al (1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: "APOE genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "predicts"

Phrase: "when"

Phrase: "-"

Phrase: "not whetherone"

Phrase: "is"

Phrase: "predisposed to Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0231203:Predisposed [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.298: Nature Genetics, 19, 321-322.[CrossRef][Medline] Mortel, K. 

Phrase: "Nature Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: "19,"

Phrase: "321-322."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mortel,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.299: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.300: & Meyer, J. 

Phrase: "& Meyer,"

Phrase: "J."
Processing 00000000.tx.301: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.302: (1995) Lack of postmenopausal estrogen therapy and risk of dementia. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Lack of postmenopausal estrogen therapy"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]
   760   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   760   C0039798:therapy [Functional Concept]
   760   C0087111:Therapy [Therapeutic or Preventive Procedure]
   760   C0232970:postmenopausal [Temporal Concept]
   760   C0332268:lack [Qualitative Concept]
   760   C1363945:Therapy [Finding]
   760   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "and"

Phrase: "risk of dementia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.303: Journal of Neuropsychiatry and Clinical Neuroscience, 14, 332-337. 

Phrase: "Journal of Neuropsychiatry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "Clinical Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "14,"

Phrase: "332-337."
Processing 00000000.tx.304: Mulnard, R. 

Phrase: "Mulnard,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.305: A., Cotman, C. 

Phrase: "A.,"

Phrase: "Cotman,"

Phrase: "C."
Processing 00000000.tx.306: W., Kawas, C. 

Phrase: "W., Kawas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0521083:Kawas [Plant]

Phrase: "C."
Processing 00000000.tx.307: W. 

Phrase: "W."
Processing 00000000.tx.308: (2000) Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   775   C0014935:Estrogen Replacement Therapy [Therapeutic or Preventive Procedure]
           Estrogen Replacement
   756   C0086258:Estrogen Replacement [Therapeutic or Preventive Procedure]
   756   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   754   C0279494:estrogen therapy [Therapeutic or Preventive Procedure]
   738   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   738   C0035139:Replacement [Therapeutic or Preventive Procedure]
   738   C0039798:therapy [Functional Concept]
   738   C0087111:Therapy [Therapeutic or Preventive Procedure]
   738   C0559956:Replacement [Functional Concept]
   738   C1363945:Therapy [Finding]
   738   C1555302:Replacement [Idea or Concept]
   738   C2936882:Estrogen [Pharmacologic Substance]

Phrase: ":"

Phrase: "a randomized controlled trial."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0282440:randomized controlled trial [Intellectual Product,Research Activity]
  1000   C1096777:Randomized Controlled Trial [Intellectual Product,Research Activity]
   827   C0008976:Trial [Research Activity]
   827   C0034656:randomized [Research Activity]
   827   C2587213:Controlled [Functional Concept]
   793 E C0243148:control [Qualitative Concept]
   793 E C1550141:Control [Substance]
   793 E C1882979:Control [Conceptual Entity]
   793 E C3274648:Control [Qualitative Concept]
Processing 00000000.tx.309: Alzheimer's Disease Cooperative Study. 

Phrase: "Alzheimer's Disease Cooperative Study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0596382:cooperative study [Research Activity]
   812   C0557651:Study [Manufactured Object]
   812   C0679729:cooperative [Organization]
   812   C2603343:Study [Research Activity]
Processing 00000000.tx.310: Journal of the American Medical Association, 283, 1007-1015.[Abstract/Free FullText] Naslund, J., Haroutonian, V., Mohs, R., et al (2000) Correlation between elevated levels of amyloid B-peptide in the brain and cognitive decline. 

Phrase: "Journal of the American Medical Association,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "283,"

Phrase: "1007-1015."

Phrase: "[Abstract/Free FullText"

Phrase: "] Naslund,"

Phrase: "J.,"

Phrase: "Haroutonian,"

Phrase: "V.,"

Phrase: "Mohs,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "et al (2000"

Phrase: ")"

Phrase: "Correlation between elevated levels of amyloid B-peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1707520:Correlation [Qualitative Concept]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "cognitive decline."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
Processing 00000000.tx.311: Journal of the American Medical Association, 283, 1571-1577.[Abstract/Free FullText] Paganini-Hill, A. 

Phrase: "Journal of the American Medical Association,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "283,"

Phrase: "1571-1577."

Phrase: "[Abstract/Free FullText"

Phrase: "] Paganini-Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]

Phrase: "A."
Processing 00000000.tx.312: & Henderson, V. 

Phrase: "& Henderson,"

Phrase: "V."
Processing 00000000.tx.313: W. 

Phrase: "W."
Processing 00000000.tx.314: (1994) Estrogen deficiency and risk of Alzheimer's disease in women. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Estrogen deficiency"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0853662:estrogen deficiency [Disease or Syndrome]
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: "and"

Phrase: "risk of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1281905:disease risk [Finding]
   770   C0035647:Risk [Qualitative Concept]

Phrase: "in women."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]
Processing 00000000.tx.315: American Journal of Epidemiology, 140, 256-261.[Abstract] Petanceska, S. 

Phrase: "American Journal of Epidemiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "140,"

Phrase: "256-261."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Petanceska,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.316: S., Nagy, V., Frail, D., et al (2000) Ovariectomy and 17 beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. 

Phrase: "S."

Phrase: ","

Phrase: "Nagy,"

Phrase: "V.,"

Phrase: "Frail,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871754:Frail [Finding]
   928 E C0424594:Frailty [Finding]

Phrase: "D."

Phrase: ","

Phrase: "et al (2000"

Phrase: ")"

Phrase: "Ovariectomy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029936:Ovariectomy [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "17 beta-estradiol"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0014912:17 beta-Estradiol [Hormone,Pharmacologic Substance,Steroid]
           Estradiol
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
   771 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   771 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the levels of Alzheimer's amyloid beta peptides"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.317: Neurology, 27, 2212-2217. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "27,"

Phrase: "2212-2217."
Processing 00000000.tx.318: Polvikoski, T., Sulkava, R., Haltia, M., et al (1995) Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. 

Phrase: "Polvikoski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sulkava,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Haltia,"

Phrase: "M."

Phrase: ","

Phrase: "et al (1995"

Phrase: ")"

Phrase: "Apolipoprotein E,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "dementia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "cortical deposition of beta-amyloid protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0011560:Amyloid deposition [Pathologic Function]
   783   C0333584:Protein deposition [Pathologic Function]
   783   C1705760:Amyloid Deposition [Finding]
   753   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.319: New England Journal of Medicine, 333, 1242-1247.[Abstract/Free FullText] Prasher, V. 

Phrase: "New England Journal of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "333,"

Phrase: "1242-1247."

Phrase: "[Abstract/Free FullText"

Phrase: "] Prasher,"

Phrase: "V."
Processing 00000000.tx.320: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.321: & Krishnan, V. 

Phrase: "& Krishnan,"

Phrase: "V."
Processing 00000000.tx.322: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.323: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.324: (1993) Age of onset and duration of dementia in people with Down syndrome: Integration of 98 reported cases in the literature. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Age of onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   790   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "duration of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449238:Duration [Temporal Concept]
   790   C2926735:Duration [Pharmacologic Substance]

Phrase: "in people"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027361:People [Population Group]

Phrase: "with Down syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: ":"

Phrase: "Integration of 98 reported cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1158478:Integration [Genetic Function]
   760   C1705422:Integration [Machine Activity]

Phrase: "in the literature."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023866:Literature [Intellectual Product]
  1000   C0034036:LITERATURE [Intellectual Product,Manufactured Object]
Processing 00000000.tx.325: International Journal of Geriatric Psychiatry, 10, 25-31. 

Phrase: "International Journal of Geriatric Psychiatry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "10,"

Phrase: "25-31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]
Processing 00000000.tx.326: Prasher, V. 

Phrase: "Prasher,"

Phrase: "V."
Processing 00000000.tx.327: P., Chowdhury, T. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Chowdhury,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.328: A., Rowe, B. 

Phrase: "A.,"

Phrase: "Rowe,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.329: R., et al (1997) ApoE genotype and Alzheimer's disease in adults with Down syndrome: meta-analysis. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "et al (1997"

Phrase: ")"

Phrase: "ApoE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "Alzheimer's disease in adults"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0277562:adults disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "with Down syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: ":"

Phrase: "meta-analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.330: American Journal of Mental Retardation, 102, 103-110.[Medline] Prasher, V. 

Phrase: "American Journal of Mental Retardation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "102,"

Phrase: "103-110."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Prasher,"

Phrase: "V."
Processing 00000000.tx.331: P., Farrer, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Farrer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.332: J., Kessling, A. 

Phrase: "J.,"

Phrase: "Kessling,"

Phrase: "A."
Processing 00000000.tx.333: M., et al (1998) Molecular mapping of Alzheimer-type dementia in Down's syndrome. 

Phrase: "M."

Phrase: ","

Phrase: "et al (1998"

Phrase: ")"

Phrase: "Molecular mapping of Alzheimer-type dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1283195:Mapping [Activity]

Phrase: "in Down's syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.334: Annals of Neurology, 43, 380-383.[Medline] Raghavan, R., Khin-Nu, C., Brown, A. 

Phrase: "Annals of Neurology,"

Phrase: "43,"

Phrase: "380-383."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Raghavan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Khin-Nu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439100:Nu [Intellectual Product]
   861   C1419003:NU [Gene or Genome]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "A."
Processing 00000000.tx.335: G., et al (1994) Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21). 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "et al (1994"

Phrase: ")"

Phrase: "Gender differences in the phenotypic expression of Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0036866:gender differences [Organism Attribute]
   708   C1705241:*Difference [Quantitative Concept]
   708   C1705242:Difference [Qualitative Concept]

Phrase: "in Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "(trisomy 21"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013080:Trisomy 21 [Congenital Abnormality,Disease or Syndrome]
  1000   C3537167:Trisomy 21 [Cell or Molecular Dysfunction]
   861   C0041107:Trisomy [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.336: Neuroreport, 5, 1393-1396.[Medline] Roses, A. 

Phrase: "Neuroreport,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "1393-1396."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.337: D., Strittmatter, W.J., Pericak-Vance, M. 

Phrase: "D."

Phrase: ","

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Pericak-Vance,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.338: A., et al (1994) Clinical application of apolipoprotein E genotyping to Alzheimer's disease. 

Phrase: "A.,"

Phrase: "et al (1994"

Phrase: ")"

Phrase: "Clinical application of apolipoprotein E genotyping"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0185125:Application [Health Care Activity]
   753   C1947919:Application [Intellectual Product]
   753   C2347934:Application [Intellectual Product]
   753   C3539080:APPLICATION [Quantitative Concept]

Phrase: "to Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.339: Lancet, 343, 1564-1565.[Medline] Royston, M., Mann, D., Pickering-Brown, S., et al (1994) Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "343,"

Phrase: "1564-1565."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Royston,"

Phrase: "M."

Phrase: ","

Phrase: "Mann,"

Phrase: "D."

Phrase: ","

Phrase: "Pickering-Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "S."

Phrase: ","

Phrase: "et al (1994"

Phrase: ")"

Phrase: "Apolipoprotein E epsilon 2 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0002085:Allele [Gene or Genome]
   722   C0052198:Apolipoprotein E-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "longevity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023980:Longevity [Temporal Concept]

Phrase: "and"

Phrase: "protects"

Phrase: "patients with Down's syndrome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "from dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.340: Neuroreport, 20, 2583-2585. 

Phrase: "Neuroreport,"

Phrase: "20,"

Phrase: "2583-2585."
Processing 00000000.tx.341: Rubinsztein, D. 

Phrase: "Rubinsztein,"

Phrase: "D."
Processing 00000000.tx.342: C., Hon, J., Stevens, F., et al (1999) ApoE genotypes and risk of dementia in Down syndrome. 

Phrase: "C., Hon,"

Phrase: "J.,"

Phrase: "Stevens,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551756:Stevens [Population Group]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "et al (1999"

Phrase: ")"

Phrase: "ApoE genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "and"

Phrase: "risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]

Phrase: "in Down syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.343: American Journal of Medical Genetics, 88, 344-347.[CrossRef][Medline] Rumble, B., Retallack, R., Hillbach, C., et al (1989) Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. 

Phrase: "American Journal of Medical Genetics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "88,"

Phrase: "344-347."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rumble,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Retallack,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hillbach,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "et al (1989"

Phrase: ")"

Phrase: "Amyloid A4 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "its precursor in Down's syndrome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.344: New England Journal of Medicine, 320, 1446-1452.[Abstract] Saunders, A. 

Phrase: "New England Journal of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "320,"

Phrase: "1446-1452."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Saunders,"

Phrase: "A."
Processing 00000000.tx.345: M., Schmader, K., Breitner, J. 

Phrase: "M."

Phrase: ","

Phrase: "Schmader,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Breitner,"

Phrase: "J."
Processing 00000000.tx.346: C., et al (1993) Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. 

Phrase: "C., et al (1993"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: "Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   738   C0037775:Distributions [Spatial Concept]
   704 E C0520511:distribution [Idea or Concept]
   704 E C1704711:Distribution [Functional Concept]

Phrase: "and in other amyloid-forming diseases."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   783   C0002726:amyloid diseases [Disease or Syndrome]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0012634:Diseases [Disease or Syndrome]
   753   C0205431:Forming [Functional Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1515981:And [Idea or Concept]
   753   C1522492:Forming [Functional Concept]
   719 E C0348078:Form [Qualitative Concept]
   719 E C0376315:Form [Manufactured Object]
Processing 00000000.tx.347: Lancet, 342, 710-711.[Medline] Scheuner, D., Eckman, C., Jensen, M., et al (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease in increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "342,"

Phrase: "710-711."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Scheuner,"

Phrase: "D."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Jensen,"

Phrase: "M."

Phrase: ","

Phrase: "et al (1996"

Phrase: ")"

Phrase: "Secreted amyloid beta-protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   923   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1750295:beta protein [Genetic Function]
   861   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   861   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C2004068:Beta [Qualitative Concept]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "in the senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "in increased in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "by the presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "APP mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "linked to familial Alzheimer's disease."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.348: Nature Medicine, 2, 864-870.[Medline] Schupf, N., Kapell, D., Lee, J. 

Phrase: "Nature Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "864-870."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schupf,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kapell,"

Phrase: "D."

Phrase: ","

Phrase: "Lee,"

Phrase: "J."
Processing 00000000.tx.349: H., et al (1996) Onset of dementia is associated with apolipoprotein E 4 in Down syndrome. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "et al (1996"

Phrase: ")"

Phrase: "Onset of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332162:Onset [Qualitative Concept]

Phrase: "is"

Phrase: "associated with apolipoprotein E 4"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   862   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   806   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in Down syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.350: Annals of Neurology, 40, 799-801.[Medline] Schupf, N., Kapell, D., Nightingale, B., et al (1998) Earlier onset of Alzheimer's disease in men with Down syndrome. 

Phrase: "Annals of Neurology,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "799-801."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schupf,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kapell,"

Phrase: "D."

Phrase: ","

Phrase: "Nightingale,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326597:Nightingale, NOS [Bird]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "et al (1998"

Phrase: ")"

Phrase: "Earlier onset of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   879   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   824   C0814120:early disease onset [Disease or Syndrome]
   797   C0277793:disease onset [Temporal Concept]
   790   C1833334:Early-onset [Finding]
   760   C0332162:Onset [Qualitative Concept]

Phrase: "in men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]

Phrase: "with Down syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.351: Neurology, 50, 991-995.[Abstract] Schupf, N., Patel, B., Silverman, W., et al (2001) Elevated plasma amyloid -peptide !-42 and onset of dementia in Down syndrome. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "50,"

Phrase: "991-995."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Schupf,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Patel,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Silverman,"

Phrase: "W.,"

Phrase: "et al (2001"

Phrase: ")"

Phrase: "Elevated plasma amyloid -peptide !-42"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   804   C0032105:Plasma [Body Substance]
   804   C0205250:Elevated [Qualitative Concept]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   804   C3163633:Elevated [Qualitative Concept]

Phrase: "and"

Phrase: "onset of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332162:Onset [Qualitative Concept]

Phrase: "in Down syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.352: Neuroscience Letters, 301, 199-203.[CrossRef][Medline] Scott, W. 

Phrase: "Neuroscience Letters,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0282413:letters [Intellectual Product]
   827 E C1096774:Letter [Intellectual Product]
   827 E C2360551:Letter [Clinical Attribute]
   789 E C0079691:Levothyroxine Sodium [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   768 E C0728762:Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "301,"

Phrase: "199-203."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Scott,"

Phrase: "W."
Processing 00000000.tx.353: K., Growden, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Growden,"

Phrase: "J."
Processing 00000000.tx.354: H., Roses, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.355: D., et al (1996) Presenilin-1 polymorphism and Alzheimer's disease. 

Phrase: "D."

Phrase: ","

Phrase: "et al (1996"

Phrase: ")"

Phrase: "Presenilin-1 polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.356: Lancet, 347, 1186-1187.[Medline] Sekijima, Y., Ikeda, S., Tokuda, T., et al (1998) Prevalence of dementia of the Alzheimer type and apolipoprotein E phenotypes in aged patients with Down syndrome. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "347,"

Phrase: "1186-1187."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sekijima,"

Phrase: "Y.,"

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "S."

Phrase: ","

Phrase: "Tokuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "et al (1998"

Phrase: ")"

Phrase: "Prevalence of dementia of the Alzheimer type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0033105:Prevalence [Quantitative Concept]
   748   C0220900:prevalence [Quantitative Concept]

Phrase: "and"

Phrase: "apolipoprotein E phenotypes in aged patients"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   816   C0428504:Apolipoprotein E phenotype [Laboratory or Test Result]
   816   C0430038:Apolipoprotein E phenotype [Laboratory Procedure]
   753   C0031437:Phenotypes [Organism Attribute]
   719 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "with Down syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.357: European Neurology, 39, 234-237.[Medline] Sherrington, R., Rogaev, E. 

Phrase: "European Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "39,"

Phrase: "234-237."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaev,"

Phrase: "E."
Processing 00000000.tx.358: I., Liang, Y., et al (1995) Cloning of a novel gene bearing missense mutations in early familial Alzheimer's disease. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "et al (1995"

Phrase: ")"

Phrase: "Cloning of a novel gene bearing missense mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0598888:Gene Cloning [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0009015:Cloning [Research Activity]

Phrase: "in early familial Alzheimer's disease."
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   923   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   875   C0277558:Familial disease [Disease or Syndrome]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   839 E C0344339:family disease [Finding]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0015576:familial [Family Group]
   812   C0241888:Familial [Functional Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
   741 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.359: Nature, 375, 754-760.[CrossRef][Medline] Tang, M. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "375,"

Phrase: "754-760."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tang,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.360: X., Jacobs, D., Stern, Y., et al (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. 

Phrase: "X.,"

Phrase: "Jacobs,"

Phrase: "D."

Phrase: ","

Phrase: "Stern,"

Phrase: "Y.,"

Phrase: "et al (1996"

Phrase: ")"

Phrase: "Effect of oestrogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0877035:Estrogen Effect [Finding]
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "during menopause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025320:Menopause [Physiologic Function]
  1000   C0567312:Menopause [Finding]

Phrase: "on risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "age at onset of Alzheimer's disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   783   C0277793:disease onset [Temporal Concept]
   753   C0001779:Age [Organism Attribute]
   753   C0332162:Onset [Qualitative Concept]
Processing 00000000.tx.361: Lancet, 348, 429-432.[CrossRef][Medline] Tokuda, T., Fukushima, T., Ikeda, S.-I., et al (1997) Plasma levels of amyloid -proteins AB1-40 and AB1-42(43) are elevated in Down's syndrome. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "348,"

Phrase: "429-432."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tokuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Fukushima,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "S.-I.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603362:S' [Clinical Attribute]

Phrase: "et al (1997"

Phrase: ")"

Phrase: "Plasma levels of amyloid -proteins AB1-40"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   774   C0032120:Plasma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757 E C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757 E C1168405:protein plasma [Laboratory Procedure]
   748   C0032105:Plasma [Body Substance]
   748   C0441889:Levels [Qualitative Concept]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   741   C0428479:Protein level [Laboratory or Test Result]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "AB1-42"

Phrase: "(43"

Phrase: ")"

Phrase: "are"

Phrase: "elevated in Down's syndrome."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   770   C0039082:Syndrome [Disease or Syndrome]
   770   C0205250:Elevated [Qualitative Concept]
   770   C3163633:Elevated [Qualitative Concept]
   715   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   715   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.362: Annals of Neurology, 41, 271-273.[Medline] Toran-Allerand, C. 

Phrase: "Annals of Neurology,"

Phrase: "41,"

Phrase: "271-273."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Toran-Allerand,"

Phrase: "C."
Processing 00000000.tx.363: D., Miranda, R. 

Phrase: "D."

Phrase: ","

Phrase: "Miranda,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.364: C., Bentham, W. 

Phrase: "C., Bentham,"

Phrase: "W."
Processing 00000000.tx.365: D., et al (1992) Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. 

Phrase: "D."

Phrase: ","

Phrase: "et al (1992"

Phrase: ")"

Phrase: "Estrogen receptors"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0034804:Estrogen Receptors [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   966 E C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "colocalize with low-affinity nerve growth factor receptors"
Meta Candidates (Total=26; Excluded=2; Pruned=0; Remaining=24)
   876   C0254837:Nerve Growth Factor Receptor, Low-Affinity [Amino Acid, Peptide, or Protein,Receptor]
       E   Receptor, Nerve Growth Factor
   876   C1334879:low affinity nerve growth factor receptor [Gene or Genome]
       E   NERVE GROWTH FACTOR RECEPTOR
   833   C0132173:Receptors, Nerve Growth Factor [Amino Acid, Peptide, or Protein,Receptor]
   800   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C0206454:Growth Factor Receptors [Amino Acid, Peptide, or Protein,Receptor]
   800   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0027740:Nerve [Tissue]
   744   C0027757:NERVE [Tissue]
   744   C0205251:low [Qualitative Concept]
   744   C0220844:growth [Physiologic Function]
   744   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   744   C1280541:Nerve [Body Part, Organ, or Organ Component]
   744   C1299352:Low [Qualitative Concept]
   744   C1510827:Affinity [Natural Phenomenon or Process]
   744   C1521761:Factor [Functional Concept]
   744   C1550472:low [Idea or Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   743   C0814002:Neural Growth [Cell Function,Organism Function]
   739   C0034837:Receptors, Neural [Cell Component]

Phrase: "in cholinergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C2333949:Cholinergic Neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "of the basal forebrain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2331620:Basal forebrain [Body Part, Organ, or Organ Component]
   861   C0085140:Fore-Brain [Body Part, Organ, or Organ Component]
   861   C0205112:Basal [Spatial Concept]
Processing 00000000.tx.366: Proceedings of the National Academy of Science USA, 89, 4668-4672.[Abstract] Tyrrell, J., Cosgrave, M., Hawi, Z., et al (1998) A protective effect of apolipoprotein E e2 allele on dementia in Down's syndrome. 

Phrase: "Proceedings of the National Academy of Science USA,"

Phrase: "89,"

Phrase: "4668-4672."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Tyrrell,"

Phrase: "J.,"

Phrase: "Cosgrave,"

Phrase: "M."

Phrase: ","

Phrase: "Hawi,"

Phrase: "Z.,"

Phrase: "et al (1998"

Phrase: ")"

Phrase: "A protective effect of apolipoprotein E e2 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "in Down's syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.367: Biological Psychiatry, 43, 397-400.[CrossRef][Medline] Tyrrell, J., Cosgrave, M., McPherson, J., et al (1999) Presenilin 1 and alpha-1-antichymotrypsin polymorphisms in Down syndrome: no effect on the presence of dementia. 

Phrase: "Biological Psychiatry,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0005523:Biological Psychiatry [Biomedical Occupation or Discipline]
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0033872:Psychiatry [Professional or Occupational Group]
   861   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   861   C0205460:biological [Qualitative Concept]
   789 E C0205487:Psychiatric [Functional Concept]

Phrase: "43,"

Phrase: "397-400."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tyrrell,"

Phrase: "J.,"

Phrase: "Cosgrave,"

Phrase: "M."

Phrase: ","

Phrase: "McPherson,"

Phrase: "J.,"

Phrase: "et al (1999"

Phrase: ")"

Phrase: "Presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "alpha-1-antichymotrypsin polymorphisms in Down syndrome"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0032529:polymorphisms [Genetic Function]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: ":"

Phrase: "no effect on the presence of dementia."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.368: American Journal of Medical Genetics, 88, 616-620.[CrossRef][Medline] van Gool, W. 

Phrase: "American Journal of Medical Genetics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "88,"

Phrase: "616-620."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] van Gool,"

Phrase: "W."
Processing 00000000.tx.369: A., Evenhuis, H. 

Phrase: "A.,"

Phrase: "Evenhuis,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.370: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.371: & van Duijn, C. 

Phrase: "& van Duijn,"

Phrase: "C."
Processing 00000000.tx.372: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.373: (1995) A casecontrol study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. 

Phrase: "(1995"

Phrase: ")"

Phrase: "A casecontrol study of apolipoprotein E genotypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0007328:Case-Control Study [Research Activity]
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "associated with Down's syndrome."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0039082:Syndrome [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   715   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.374: Dutch Study Group on Down's Syndrome and Ageing. 

Phrase: "Dutch Study Group on Down's Syndrome"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0441833:Group [Idea or Concept]
   753   C0557651:Study [Manufactured Object]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "Ageing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]
Processing 00000000.tx.375: Annals of Neurology, 38, 225-230.[Medline] Visser, F. 

Phrase: "Annals of Neurology,"

Phrase: "38,"

Phrase: "225-230."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Visser,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.376: E., Aldenkamp, A. 

Phrase: "E.,"

Phrase: "Aldenkamp,"

Phrase: "A."
Processing 00000000.tx.377: P., van Huffelen, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "van Huffelen,"

Phrase: "A."
Processing 00000000.tx.378: C., et al (1997) Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome. 

Phrase: "C., et al (1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: "Prospective study of the prevalence of Alzheimer-type dementia"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0033522:prospective study [Research Activity]
   764   C1709709:Prospective Study [Research Activity]
   762   C0033106:Study, Prevalence [Quantitative Concept]
   762   C0035171:Study Type [Research Activity]
   762   C2985227:Study Type [Research Activity]
   742   C0023981:prospective [Research Activity]
   742   C0557651:Study [Manufactured Object]
   742   C2603343:Study [Research Activity]

Phrase: "in institutionalized individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "with Down syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.379: American Journal of Mental Retardation, 101, 400-412.[Medline] Wisniewski, H., Wegiel, J., Popovitch, E. 

Phrase: "American Journal of Mental Retardation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "101,"

Phrase: "400-412."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wisniewski,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wegiel,"

Phrase: "J.,"

Phrase: "Popovitch,"

Phrase: "E."
Processing 00000000.tx.380: (1995) Age-associated development of diffuse and thioflavin-S-positive plaques in Down syndrome. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Age-associated development of diffuse"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C2733260:Developmental age [Organism Attribute]
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "thioflavin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "S-"

Phrase: "positive plaques in Down syndrome."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0333463:plaques [Acquired Abnormality]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]
Processing 00000000.tx.381: Developmental Brain Dysfunction, 7, 330-339. 

Phrase: "Developmental Brain Dysfunction,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0262405:brain dysfunction [Disease or Syndrome]
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   771 E C0231174:Malfunction [Functional Concept]
   771 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "7,"

Phrase: "330-339."
Processing 00000000.tx.382: Wisniewski, T., Morelli, L., Wegiel, J., et al (1995) The influence of apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's syndrome. 

Phrase: "Wisniewski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Morelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Wegiel,"

Phrase: "J.,"

Phrase: "et al (1995"

Phrase: ")"

Phrase: "The influence of apolipoprotein E isotypes"

Phrase: "on Alzheimer's disease pathology"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "in 40 cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "of Down's syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.383: Annals of Neurology, 37, 136-138. 

Phrase: "Annals of Neurology,"

Phrase: "37,"

Phrase: "136-138."
Processing 00000000.tx.384: Wragg, M., Hutton, M. 

Phrase: "Wragg,"

Phrase: "M."

Phrase: ","

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.385: & Talbot, C. 

Phrase: "& Talbot,"

Phrase: "C."
Processing 00000000.tx.386: (1996) Genetic association between intronic polymorphism in presenilin-1 gene and late onset Alzheimer's disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Genetic association between intronic polymorphism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1328885:genetic association [Occupation or Discipline]
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "in presenilin-1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "late onset Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.387: Lancet, 347, 509-512.[CrossRef][Medline] Younkin, S. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "347,"

Phrase: "509-512."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.388: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.389: (1998) The role of A beta 42 in Alzheimer's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "The role of A beta 42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.390: Journal of Physiology Paris, 92, 289-292.[CrossRef][Medline] Zigman, W., Schupf, N., Haveman, M., et al (1997) The epidemiology of Alzheimer disease in intellectual disability: results and recommendations from an international conference. 

Phrase: "Journal of Physiology Paris,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "92,"

Phrase: "289-292."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zigman,"

Phrase: "W.,"

Phrase: "Schupf,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Haveman,"

Phrase: "M."

Phrase: ","

Phrase: "et al (1997"

Phrase: ")"

Phrase: "The epidemiology of Alzheimer disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014507:Epidemiology [Biomedical Occupation or Discipline]
   760   C0014508:epidemiology [Functional Concept]
   760   C0699910:epidemiology [Health Care Activity]

Phrase: "in intellectual disability"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0025362:Intellectual Disability [Mental or Behavioral Dysfunction]
   861   C0231170:Disability [Finding]
   789 E C0018576:Disabled [Patient or Disabled Group]
   789 E C1880351:Disabled [Qualitative Concept]

Phrase: ":"

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "and"

Phrase: "recommendations from an international conference."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034866:recommendations [Idea or Concept]
Processing 00000000.tx.391: Journal of Intellectual Disability Research, 41, 76-80.[Medline] Received for publication January 5, 2001. 

Phrase: "Journal of Intellectual Disability Research,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "41,"

Phrase: "76-80."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "Received for publication January 5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2001."
Processing 00000000.tx.392: Revision received June 8, 2001. 

Phrase: "Revision"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439617:Revision [Temporal Concept]
  1000   C0558347:Revision [Therapeutic or Preventive Procedure]
  1000   C1527075:Revision [Therapeutic or Preventive Procedure]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "June 8,"

Phrase: "2001."
Processing 00000000.tx.393: Accepted for publication June 13, 2001.

Phrase: "Accepted for publication June 13,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   760   C1704324:Publication [Intellectual Product]
   726 E C1548601:Accept [Idea or Concept]

Phrase: "2001."

